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 LETTER FROM THE DEAN 1
A	Productive	Year
My first year as Dean of the University of Colorado School of Medicine has been a ful-
filling and rewarding experience.
In January, we announced five projects that were awarded Transformational Research 
Funding grants, totaling $80 million over five years, to bolster initiatives that show great 
promise for our School, for the health of our patients and community and for medical 
science in general.
The Office of Medical Education has been immersed in preparation for the March 2017 
site visit by the Liaison Committee for Medical Education, which accredits medical 
schools. The dedication of our staff, led by Senior Associate Dean Robert Anderson, 
MD, and working with dozens of faculty, are ensuring that we have focused attention on 
the myriad details necessary for this important event.
The School of Medicine branch in Colorado Springs became home to the first group of 
students who will conduct their third-year clinical rotations there. Associate Dean Erik 
Wallace, MD, has spent two years building relationships with providers in the commu-
nity and overseeing the implementation of the curriculum.
The clinicians on our faculty continue to provide the best care in our community and 
offer the solid foundation on which our School depends. Our faculty and our practice 
plan, University Physicians, Inc., offer considerable funding to support the School’s 
operations, create endowed chairs and provide student scholarships.
We are implementing a plan that will ensure that we are using research space on cam-
pus to its best potential. While that process can be difficult for some, it is essential to 
our future. We cannot recruit and retain the best faculty with a scattershot plan for using our space. The sensible principles we are putting in place 
will ensure we have productive laboratories and that we are locating investigators with common interests near one another.
The School received one of the largest programmatic gifts in its history in April 2015, when the Helen K. and Arthur E. Johnson Foundation gave 
a $10 million grant to support the Depression Center. In honor of the donors, the CU Board of Regents voted to rename the center the Helen and 
Arthur E. Johnson Depression Center.
And in March 2016, the University announced a $10 million pledge from The Anschutz Foundation to support establishing the National Behavioral 
Health Innovation Center, which will bring innovative approaches for preventing, identifying and treating behavioral health and substance abuse.
The Transformational Research Funding grants, which I previously mentioned, are a significant investment in our future. We are funding areas of re-
search that will have high impact, nurture cross-disciplinary collaboration, and involve partners from other institutions. Those projects are described 
in this issue, page 26, and on the School of Medicine’s website.
We are able to make these investments with funding provided by the clinical earnings of the faculty, from annual financial support from the Univer-
sity of Colorado Health and from philanthropy, including a commitment of $15 million by The Anschutz Foundation. No state-appropriated dollars 
or student tuition or fees are being used for the Transformational Research Funding awards. 
What we discovered in the process of selecting the award recipients was not a surprise: This campus is home to an abundance of immensely talented 
people. In fact, we received so many excellent proposals that it was a reminder that my work as Dean is never done.  Just as our clinicians always 
strive to improve care, our teachers work constantly to provide the best education and our researchers remain committed to advancing the frontiers 
of knowledge, it is my job to provide the best conditions possible for them to excel.
 With warm regards,
 John J. Reilly, Jr., MD 
 Richard D. Krugman Endowed Chair 
 Dean, School of Medicine 
 Vice Chancellor for Health Affairs
Huntington Potter, PhD, professor of neurol-
ogy and director of the Rocky Mountain Al-
zheimer’s Disease Center, told the Denver Post 
in March that amyloid deposits are like “little 
Brillo pads of deposited proteins” believed to 
be involved in killing brain neurons.
William Hiatt, MD, professor of medicine and 
president of the Colorado Prevention Center, 
discussed athletes’ use of meldonium in a New 
York Times article. “Glucose is more efficient 
when you have limited oxygen,” he said. “I can 
only see a downside to inhibiting carnitine in a 
healthy athlete.”
Richard Zane, MD, chair of emergency 
medicine, wrote an article, “How We Trans-
formed Emergency Care at Our Hospital,” that 
appeared in December in the Harvard Business 
Review: “At the University of Colorado Hospi-
tal ED, which I am privileged to lead, we real-
ized that more space alone wouldn’t save us. So 
we took a different approach, building a highly 
integrated leadership team that sets a new 
standard for emergency care, with the needs of 
patients (not providers) as the driving force.”
Hillary Lum, MD, PhD, assistant professor of 
medicine in the Division of Geriatric Medicine, 
commented in the Denver Post in March on 
the increase in end-of-life conversations with 
patients. “In a best-case situation,” she said, 
“excellent primary care physicians already are 
having this conversation. But because it’s time-
consuming, sometimes they run behind, and 
it’s hard to fit those conversations in.”
Matthew Wynia, MD, MPH, director of the 
Center for Bioethics and Humanities, was quot-
ed as an expert on medical board procedures 
in the Portland (Maine) Press Herald in March. 
“[Medical boards] may approach the meetings 
very thoughtfully,” he said. “But since they’re all 
doctors, or most of them are, they are going to 
be sympathetic to the difficulties of practicing 
medicine, and will lean in that direction.”
Carol Foster, MD, director of the Balance 
Laboratory at University of Colorado Hospital 
and associate professor of otolaryngology, dis-
cussed benign paroxysmal positional vertigo in 
a February article in The New York Times. This 
kind of vertigo occurs more frequently in older 
adults, apparently because the protein coating 
that holds the crystals in place weakens with 
age. “Like an old Post-it note, after 60 or 70 
years the stickiness wears off,” she said.
Patricia Braun, MD, associate professor of pe-
diatrics, was quoted on National Public Radio 
in February noting that the crisis of contami-
nated water in Flint, Mich., is making it harder 
to explain that tap water in most communities 
is safe to drink.
Heather Young, MD, assistant professor of 
medicine in the Division of Infectious Diseases 
and epidemiologist at Denver Health Medi-
cal Center, told the Denver CBS affiliate that a 
mumps outbreak was being investigated in the 
city after patients began showing symptoms. 
“All had some jaw swelling in this region which 
is pretty common for mumps. They also had 
low grade temperatures and just felt ill,” she 
said. A lack of awareness about mumps in the 
community allows the disease to spread easily.
Andrew Monte, MD, assistant professor of 
emergency medicine, discussed with CNN and 
the Los Angeles Times his findings in the New 
England Journal of Medicine in February that 
marijuana tourism in Colorado was resulting in 
more emergency room visits. “People coming 
in from out of state might have less experience 
with the particular products available here, 
and they might be using in excess because 
they are on vacation,” he said. “It’s kind of like 
how people drink heavily when they go to Las 
Vegas.” 
In an interview with the NBC affiliate in Den-
ver in December, Jean Mulcahy Levy, MD, 
assistant professor of pediatrics, discussed her 
passion for medicine: “My goal is not only to 
cure cancer, but my goal is to cure kids with 
cancer so they have a good life.”
Susan Hwang, MD, MPH, assistant profes-
sor of pediatrics, and Camille Hoffman, MD, 
assistant professor of obstetrics and gynecol-
ogy, were quoted in a February report on the 
Denver NBC affiliate, 9News, discussing infant 
mortality rates among African Americans. 
“Even if you take the wealthiest black woman, 
her rate of preterm birth is still higher than the 
poorest white woman,” Hwang said. “Stud-
ies have demonstrated that maternal reports 
of racism have resulted in high rates of stress, 
inflammation and preterm birth.”
Robert Eckel, MD, professor of medicine, was 
quoted in a February Time magazine article 
about whether egg yolks were unhealthy. “Eggs 
get a lot of attention because they’re so popular 
and for a while were kind of vilified,” he said. 
“But I’m a lot more concerned about people 
eating more fruits and vegetables, and adhering 
to a healthy dietary pattern like a Mediterra-
nean-style diet or the DASH diet.”
















Reporters locally and nationally turn to the School of Medicine for  
expertise and research news. Here are examples from near and far.
      
Paritosh Kaul, MD, associate professor of pe-
diatrics, commented on National Public Radio 
in a report about the awareness of young men 
and emergency contraception. “The boys are 
listening, and health care providers need to talk 
to the boys,” he said. “These guys believe they 
should be involved in sexual health decision-
making. And if they are, then they’re more 
likely to talk with their girlfriends. They’re the 
missing half. It takes two to tango.” 
Stephen Berman, MD, professor of pediatrics 
and former president of the American Academy 
of Pediatrics, discussed a February trip to Cuba 
by a delegation of physicians. “As Cubans gain 
access to new medications and technology, 
training will become very important,” he told 
the Denver Post. “We would like to eventu-
ally establish an exchange program so Cuban 
doctors can come and train here at Children’s 
Colorado and vice versa.”
Thomas Delong, PhD, assistant professor 
of immunology and microbiology, explained 
his research breakthrough related to Type 1 
diabetes, published in the journal Science, in 
a February report on the Denver CBS affiliate. 
“We found a new type of protein modification,” 
he said. “Because the immune system sees that 
and thinks it might be foreign because it’s never 
seen that before, it attacks the junction of these 
proteins.”
Omer Mei-Dan, MD, associate professor of 
orthopedics, was featured in a CNN report, “5 
Reasons Why People Jump Off Cliffs for Fun,” 
that aired in January. The report quotes a study 
of BASE jumping by Mei-Dan, who is a BASE 
jumper himself, that concluded: “Almost all 
active BASE jumpers witnessed the death or se-
vere injury of another BASE jumper. Although 
direct comparison with other sports is difficult, 
we believe the results of this study suggest that 
BASE jumping may be the most dangerous 
extreme sport.”
David Olds, PhD, professor of pediatrics and 
founder of the Nurse-Family Partnership, told 
the PBS Newshour in January that home visits 
to low-income first-time mothers can lead to 
improved cognitive development and language 
skills for their children: “All of that earli-
est process sets in motion a positive cycle of 
interaction that leads to significant reductions 
in children’s behavioral problems when they 
enter school, significant improvements in their 
language development.”
John J. Reilly, Jr., MD, dean of the School of 
Medicine, was among many faculty members 
featured in a January article in 5280 magazine 
about personalized medicine. “Strictly speak-
ing, your DNA sequence is the ultimate per-
sonal identifier,” he said, “much more so than 
your Social Security number. It’s what makes it 
such a powerful tool in forensics.”
Cecilia Pascual-Garrido, MD, assistant profes-
sor of orthopedics, commented on the use of 
stem-cell therapy for a February report on the 
Denver Fox affiliate. “I think it’s going to be a 
revolution in orthopedics,” she said. “The time 
that we have to treat these patients is the time 
between when they were active and happy and 
between when they really need a hip replace-
ment.”
Frederick Grover, MD, professor of surgery, 
and David Fullerton, MD, discussed a trip to 
Nepal, where they performed surgery as part of 
a church mission. “When people think of Third 
World countries, they tend to focus on exotic 
diseases,” Fullerton said. “But the cardiovas-
cular diseases and chronic diseases are rapidly 
becoming the leading cause of death in Third 
World countries.”
A feature report on the Denver NBC affiliate, 
9News, in December featured a 10-year-old 
boy with spinal muscular atrophy. Sumeet 
Garg, MD, assistant professor of orthope-
dics, explained the boy’s condition: “This is a 
progressive disorder where you start losing the 
strength of your muscles.”
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Infection Prevention is Everybody’s Job
Michelle Barron works to control the spread of infectious diseases
By Cynthia Pasquale
Several years ago, Michelle Barron, MD, and a team of 
residents and interns were walking through the oc-
casionally confusing halls of one of the medical build-
ings on the University of Colorado Anschutz Medi-
cal Campus. She had the lead, walking purposefully 
ahead, and opened a door for everyone to step inside 
– the janitor’s closet.
It is a story she likes to tell, reminding people 
that she has no sense of direction. She may not 
always know west from east without a clear 
view of the mountains, but she has a firm sense 
of direction on getting from point A to point 
B when it comes to the study of infectious 
diseases.
“Follow me and you never know where you’ll 
end up; you’ll go places where you never knew 
you would go before,” she jokes. In truth, as an 
associate professor in the Division of Infectious 
Diseases at the CU School of Medicine at the 
Anschutz Medical Campus, Barron’s research 
often deals with mysteries, and, for her, that’s 
part of the appeal of her job.
“It excites me. I will always have a job that is 
stimulating and completely different from day 
to day,” she says. Currently, she’s researching 
resistant organisms, hoping to figure out how 
to identify and combat them. “It’s interesting 
work with a lot of unknowns. You never know what to expect.”
She came to the university in 1999 to serve a fellowship in infectious 
diseases and “fell in love with Colorado” and the institution. Barron’s 
research focus is on infection control – especially in hospitals – fungal 
infections, transplant infectious diseases and HIV care.
How did you choose your career path?
At the age of 4, I started telling everyone that I wanted to be a doctor. 
There are no medical personnel in my family, so I’m not sure how I came 
up with the idea. My mother tells me that I wanted to be a doctor in ad-
dition to other professions. I wanted to be a doctor-ballerina or a doctor-
astronaut, and all sorts of other interesting combinations. But I always 
wanted to be a doctor, and when I was old enough and mature enough 
to actually know what that meant, I still wanted to do it. Medicine fits. It 
suits me and I can’t imagine doing anything different.
The study of infectious diseases is my calling. When I was in medical 
school, it was during the height of the AIDS epidemic. Patients were 
dying from the disease and often from other infections. I had a lot of 
interaction with those types of patients and I kept thinking this is what I 
was going to do with my life: Help figure out how to fix this, how to pre-
vent people from getting these kinds of infections by fixing the immune 
system or something else. When you are young, you feel like you can do 
it all, but the determination has stuck and it still drives me today. That’s 
the approach I always take: ‘We can figure 
this out; we can prevent this from happening.’ 
You can only do that type of investigation and 
research in an academic setting. You can’t ask 
these questions and try things out and design 
projects to try to determine the best methods 
or science or lab work in a non-academic clini-
cal setting.
Much of your research focuses on prevent-
ing the spread of infections in hospitals. 
What has happened to help reduce institu-
tional incidents of infection?
It starts with the patient, but it is so much 
more. We talk about infection prevention 
and our mantra is: ‘It’s everybody’s job.’ That 
means it starts with the CEO of the hospital 
and continues throughout the institution, 
even with the people who don’t interact with 
patients. The role is the same: To ensure the 
environment that a person is living in while 
in the hospital is kept clean and disinfected 
appropriately, and that there are no venues for 
infections to be transported out of the room.
Many things we learned are not connected to the individual but are 
about the processes. For instance, insertion of a medical device is an area 
where using beautiful science makes a difference when it comes to pre-
venting infections. If you standardize the processes, everybody is trained 
properly, and everyone uses a checklist – just like pilots do – it makes a 
huge difference in the infection rate.
When the processes were first standardized, there was pushback. Physi-
cians like to think that we are independent thinkers who need freedom 
to figure out the best way to do things. But the truth is doctors have 
done that with mixed results. When you apply a scientific standard – 
after testing the process to find out what is best – and everyone follows 
the standard, it has profound results. Across the United States, infections 
have decreased because the science was done, the results published 
and regulatory bodies required use of the standard. Coming up with 

















a profound impact on the way we deliver health care.
Some of your recent research looks at the Ebola virus and how to be 
ready for new emerging infectious threats. One of the newest threats 
is the Zika virus. Can what you learned about Ebola be useful in 
combatting the Zika virus?
For many years, we have worried about the next coming plague. Will it 
be the H1N1 virus? Bird flu? Or something as 
exotic as Ebola? You have to think about any 
infectious disease on an individual level and on 
a global level. It’s one of the reasons I love my 
job because I get to interact on multiple levels 
when thinking about preparedness
It’s about planning, putting systems in place 
and getting people trained for whatever hits 
the door. We need to keep employees safe 
while allowing them the ability to take care of 
patients. Ebola brought that to the forefront. 
Every hospital has to have a disaster plan in 
place, but when dealing with infectious dis-
eases, you also have to consider how to keep 
staff personnel safe while they are delivering 
effective care.
Zika illustrates once more that we live in a 
global world. You could be on a plane coming 
from Africa and stop in several cities in the 
United States, bringing with you a potentially 
infectious disease, and that could be spread to 
others in a short amount of time. In addition, 
Zika and the Chikungunya virus have this in-
teresting phenomenon where mosquitos can be 
infected by a person. The medical term is au-
tochthonous transmission. So you come back 
from Brazil after having a great time at Carnival 
and you are carrying the Zika virus. You return 
home to a place where mosquitoes that can carry the virus live. You’re in 
your garden and get bitten by a mosquito; now that local mosquito picks 
up the virus. Next, the mosquito flies into your neighbor’s yard and bites 
the neighbor, who gets the Zika virus. That begins the cycle that intro-
duces the virus into a country that doesn’t have that virus.
Ebola and Zika are not new. We’re just more able to tell you what they 
are now than we were 20 years ago. Some of these viruses have been 
around for hundreds of years and are known and have been described. 
Then we have the SARS virus, which we think is new, but we’re not sure 
because it hasn’t been described before. A lot of these viruses are highly 
related to each other, sort of like first cousins. They undergo some sort 
of mutational event, and then they aren’t recognized as first cousins, but 
as a cousin twice removed or 10 times removed. From an evolutionary 
standpoint, most organisms predate man by millions of years so their 
very existence and their ability to survive depend on being able to adapt 
to new environments.
We thought Zika was new – something other than what it was – but 
after doing the science, we found out what it 
really was. With many infectious diseases, we 
have specimens from outbreaks 20 years ago 
or 100 years ago and we can test them to find 
connections.
How do we choose which diseases are ones 
to worry about or which ones we should try 
to combat?
We would love to figure that out and what is 
that magic thing we can do. There are some 
things that are very simple that can be done 
by everyone in a developed country. If you 
control the mosquito population, for instance, 
then you would eliminate Zika from affecting 
individuals. But in resource-limited settings, 
we don’t even have reliable water sources, 
let alone the ability to remove water sources 
or control mosquitos. Ebola, though more 
complex, follows the same principle. There was 
a lack of infrastructure to contain it or prevent 
it from moving beyond where it originated. So 
realistically, to prevent or control some of these 
diseases, you need global resources and a way 
to move across language and cultural barriers.
It’s also important to remind individuals that 
they have a role and a way of contributing to 
prevention and preparedness. For instance, 
one thing individuals can do is let their doctors 
know any information that might be important about where they were, 
who they were with and what they were doing.
What is the most important thing you learned from your years in 
medicine that you try to pass on to others?
I tell students that what we do is an incredible privilege. We are involved 
in patients’ lives at the happiest points – the delivery of a baby, for in-
stance – or at the worst periods of their lives. And you meet people that 
you would never encounter otherwise, much less in these extremes. It’s 
very fulfilling to be able to observe it and learn from it and gain insight 
into your own life and expectations. I personally feel you need to reflect 


















Offering a New Vision
Naresh Mandava and CU targeting eye diseases
By Lisa Marshall
By 2020, 196 million people worldwide will suffer 
from age-related macular degeneration (AMD). That’s 
four times the global incidence of dementia, and 14 
times the number diagnosed with cancer internation-
ally each year. By 2040, according to a recent study 
published in the Lancet, incidence of AMD will soar to 
288 million.
“It is a major public health issue,” says Naresh Mandava, MD, chair of 
the Department of Ophthalmology at University of Colorado School of 
Medicine. Yet for roughly 9 out of 10 those people, no medical treat-
ment exists. “I’ve had patients in their 50s who can’t 
see their kids anymore or see well enough to go to 
work. It’s devastating. It has been a real frustration to 
see them go downhill and not have much to do for 
them.”
Fueled by that frustration, and propelled by millions 
of dollars in new funding, Mandava and his col-
leagues at the UCHealth Eye Center are, as he puts it, 
“doubling down” their efforts to find a cure for AMD. 
They’ve launched a new AMD registry which will 
follow hundreds of patients over the course of their 
disease. And with $10 million in private dona-
tions, they’ve initiated an ambitious ocular stem-cell 
program aimed at developing a retinal transplant pro-
cedure to restore sight in patients blinded by AMD. 
Meanwhile, they’re testing novel, injectable drugs 
targeting tough-to-treat “dry” macular degeneration, 
in Phase III trials. And in December 2015, Mandava 
became the first surgeon in the Rocky Mountain West 
to surgically implant a “bionic eye,” partially restoring 
the vision of a woman blind from retinitis pigmentosa 
for two decades. Ultimately, it could be used to ad-
dress macular degeneration too.
“In addition to working on our own new therapies, we’ll be among the 
first to test new technologies being developed elsewhere,” says Mandava. 
“We are attacking this on all fronts.”
Searching	for	solutions
While a similar disease exists in children, AMD is primarily a malady 
of middle-age, in which the central retina – the macula – deteriorates. 
Roughly 10 percent of patients develop “wet” or neovascular macular de-
generation, a late-stage, rapidly-progressing type in which the membrane 
under the retina breaks, prompting blood vessels to grow up through the 
breaks, leak, and bleed, scarring the macula.
“You can go from reading to not seeing anything in your vision but a big 
black spot in months,” says Mandava. The other 90 percent have the 
“dry” variety, in which retinal cells break down gradually, thinning the 
macula. 
Since 2006, numerous injectable drugs have emerged to slow vision 
loss, and even improve it, in patients with “wet” AMD. But for the “dry” 
variety, treatment has been elusive. The disease is often heralded by 
“drusen,”  dots of yellow waste deposits from withering cells, on the 
retina. Then central vision and color perception begin to fade. Ultimately, 
some develop wet AMD and others progress to advanced dry AMD, or 
geographic atrophy, in which black spots chew into the visual field. The 
question baffling researchers: Why do some patients progress swiftly 
and severely, while others stay stable? Big data can help answer it, says 
Mandava.
“Through this new registry, we’ll be able to capture very valuable data 
points that other people don’t have.” 
In 2014, Mandava recruited Anne Lynch, MD, MSPH, to head up a 
newly formed division of ophthalmic epidemiology and establish several 
new registries related to eye disease. For the AMD registry, which boasts 
Naresh Mandava, MD, implants a bionic eye in patient Jamie Carley. Photo by Michael V. Mazzanti.
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400 patients and hopes to grow to 1,000, patients submit questionnaires 
about history, diet, lifestyle, and medication use, and retinal images 
using state-of-the art scanners at each visit. They also offer up a small 
sample of blood through which – thanks to new diagnostic technology 
from Boulder-based SomaLogic – researchers can now identify 4,000 
inherent proteins. The blood is stored in a repository on campus for 
future research.
By matching blood, scans, and epidemiological data, Lynch and Mandava 
hope to identify proteins or other biomarkers associated with rapidly 
progressing disease, and someday develop drugs targeting those proteins, 
to give to patients early on. The registry could also be used to highlight 
lifestyle factors associated with slow, or fast, progression, informing 
prevention advice.
“Our patients are really interested in being part of this registry. They 
want to be part of the effort to find a cure,” says Lynch.
‘This	is	not	science	fiction’
Meanwhile, Mandava is using $10 million in private donations, raised 
over just 18 months, to work with the Gates Center for Regenerative 
Medicine at CU Anschutz to develop stem cell transplants for macular 
degeneration. Already, about 10 researchers and clinicians are working 
toward the goal and he hopes to recruit a dozen more.
“The goal here, and this is not science fiction, is to take someone with 
macular degeneration, take a patch of cells from their skin, take those 
cells to an onsite facility, make those into induced pluripotent stem 
cells, convert them into retinal cells and successfully transplant them 
into a patient eye,” he says. Already, researchers have discovered how 
to develop retinal stem cells and transplant them. Now, the challenge 
is to get them to establish connections with other ocular cells, function 
properly, and resist the processes that caused degeneration to begin with. 
“Our goal is to be the first one to do this, and have it work, in the United 
States.”
That’s not the only seemingly sci-fi project in Mandava’s sight. 
On Nov. 2, 51-year-old Johnstown resident Jamie Carley nervously lay 
down on Mandava’s operating table in the UCHealth Eye Center for a 
delicate five-hour surgery in which he implanted 
a tiny microchip in her right eye. She’d been blind 
since age 26, when the retinitis pigmentosa that had 
been killing her rods and cones since age 5 took the 
last of her sight. For eight years she’d been following 
the progress of SecondSight, a California start-up 
developing the Argus II Retinal Prosthesis System. 
The system uses a miniature video camera mounted 
on specialized glasses to transmit images to 64 elec-
trodes on the implant, which in turn send electrical 
pulses to viable retinal cells (bypassing the damaged 
ones) and on to the brain via the optic nerve. 
When Carley heard it had been FDA-approved and 
UCHealth would be offering it, she jumped on it. 
When Mandava removed her bandages and turned 
on the glasses in December, she was overwhelmed.
“It was extremely emotional,” says Carley, who was 
able to see the silhouette of her son, age 29, for the 
first time. While her vision has only been partially 
restored, she says just being able to see the outline 
of doors, and the edge of the sidewalk has already 
improved her mobility immensely. 
“I can’t wait until summer, so I can go outside and 
look at the stars, and the moon, and fireworks,” she says.
SecondSight continues to work on improving the technology in hopes of 
improving resolution and someday restoring color perception in patients. 
And it recently launched its first clinical trial, in the United Kingdom, 
testing the system in those with macular degeneration.
Given all that’s happening, Mandava sees a bright future for his patients.
“Ultimately, we think it is possible to eradicate blindness. It’s tremen-
dously exciting.”

















‘Making the Most of the Time We Have’
Justin Boley’s care offers hope and improved quality of life
By Vicki Hildner
At first, Justin Boley didn’t worry too much about the 
headaches because they didn’t seem serious. Just take 
a couple Excedrin, his mother advised him.
He wasn’t too concerned when the right word sometimes eluded him—
calling his parents’ hot tub cover an “ice cream cone.” Everyone in the 
family just got a chuckle out of that odd moment.
He didn’t even worry when he seemed to be taking more sick days than 
usual.
Why would he? He was a healthy, 23-year-old man with a good job as a 
certified nursing assistant and his whole life ahead of him.
But then came the morning when Justin woke up and could not talk. 
He knew he needed to call in sick, so he dialed the number, opened his 
mouth and no words came out.
“I was thinking straight, breathing fine, but I couldn’t speak,” he says. 
“Mostly I remember thinking, ‘This is really strange.’”
The	Diagnosis
That strange speechless morning would lead to a devastating diagnosis.
But today, with the care of a compassionate CU Cancer Center physician 
and with the use of a novel medical device, Justin Boley still believes he 
has his whole life ahead of him — even though that life may be mea-
sured in months rather than years.
“He fought to get into this world,” Brandy Boley says, looking affection-
ately at her son across the room. “Justin doesn’t do anything half-way.”
Born at 29 weeks, Justin was a 2-pound preemie who spent 3 months in 
intensive care before his parents brought him home. So it’s understand-
able that Brandy thought the worst health crisis she would ever face with 
her son happened more than two decades ago.
But when Justin’s odd symptoms persisted and became more worrisome 
— he started to have double vision, lost weight and slept more every day 
— Brandy decided it was time to seek medical care.
In January 2015, the emergency department physician at Memorial 
Hospital in Colorado Springs asked Justin to touch his nose with his 
finger. Justin couldn’t do it. The doctor ordered a scan of Justin’s brain. 
Although Justin remembers very little of what was going on during that 
time, his mother will never forget.
“As a military family, you identify life events by where you lived when 
something happened,” Brandy says. “This is how we will remember 
Colorado. A doctor saying to us, ‘We found a mass.’”
The tumor was the size of a tennis ball and it was located in Justin’s 
thalamus near the brain stem. He had the tumor biopsied on this 23rd 
birthday. Brandy remembers a physician coming into the room after the 
procedure and “gently” delivering the news.
“‘Glioblastoma’—I had never heard of it,” she says. “I heard the doctor 
say ‘grade 4 … could live 12 months.’ We were too shocked to cry. But it 
hit me that by his next birthday, Justin could be gone.”
The	Disease
Glioblastoma (GBM) has a well-deserved reputation for being one of the 
deadliest cancers. It is the most common and aggressive form of primary 
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malignant brain tumors in the United States, affecting approximately 
10,000 Americans each year. Historically, the median overall survival 
time from initial diagnosis and with optimal treatment is 15 months.
The standard treatment for GBM is surgery, followed by radiation 
therapy and chemotherapy. In Justin’s case the tumor was inoperable, a 
fact that Justin accepted with equanimity. “It’s just too much risk versus 
the reward,” he says. “They could take it out, but I might be completely 
paralyzed, which I do not think would be a better life.”
Justin Boley laughs easily and often and has a way of finding the good 
news in bad. The biopsy was good, he says, because it drained the fluid 
that had built up in his brain and relieved the pressure causing his 
double vision and speech problems. He has no complaints about the oral 
chemotherapy he takes. The radiation — not a big deal.
“Things could be worse,” Justin says, with absolutely no hint of irony. 
“What I’m going through is bad, but there are plenty of other people 
who are suffering. Sure, I’m unlucky — but I’m not the most unlucky 
person.”
That, Brandy Boley says, is an example of how Justin has “perspective.” 
She has also tried to maintain perspective driven by a single motivating 
question: “How can we make the most of the time we have?”
The answer came from Douglas Ney, MD, a neuro-oncologist at CU An-
schutz, and it took the form of a medical device that looks like a gauzy 
swim cap covering a series of Band-Aids.
The	Treatment
When the Boleys brought Justin home after the biopsy, Justin’s father 
started “nesting,” adapting the house to the potential needs of a son who 
could become increasingly disabled. For his part, Justin felt better than 
he had in a long time, and he set out to enjoy his life.
“I like talking with my mom, hanging out with friends, rooting for the 
Kansas City Chiefs,” he says. He also took the opportunity to go skydiv-
ing and surfing.
A cadre of Boley family and friends spent night and day online look-
ing for every treatment available, but it was an oncologist at Memorial 
Hospital who originally suggested that Justin contact Ney because of his 
experience with Optune, a medical device which was originally approved 
by the FDA in 2011 for recurrent GBM.
Ney and his colleagues have treated approximately 50 patients with 
Optune, making the CU Cancer Center one of the top prescribers in the 
country. “Our patients are open to alternatives,” he says. “They’re willing 
to try new things, and they’re coming from all over the country to try 
this.”
Optune is a cap covering a series of electrodes which Justin wears on 
his head as long as he wants every day. Powered by a battery pack that 
he can carry with him, Optune works nonstop, applying alternating 
low-intensity electric fields to the tissue under the electrodes — 200 
kilohertz pulsing front to back, side to side, endlessly repeating as long 
as he’s wearing the device.
“It doesn’t feel like anything,” Justin says. “Your head gets a little warm, 
but if it’s working, I don’t need to know how.”
Ney can tell you how it works — the electric fields interrupt cancer 
cell structures during division, disrupting the cell as it tries to replicate. 
While it is often difficult to get chemotherapy to work on brain tumors, 
Optune goes directly into the brain, shuts down and kills tumor cells, 
while it spares normal cells.
“It is a relatively simple concept with an incredibly complex design,” Ney 
says. “It’s quite remarkable.”
So remarkable that the first clinical trials were ended early because of 
positive results — Optune was clinically effective, adding three to five 
months to life expectancy, with better quality of life for patients and 
without the side effects that can come with chemotherapy. It is the first 
treatment with a positive trial results for GBM in the past 10 years.
At Justin’s August 2015 MRI scan, after months of chemotherapy, radia-
tion and Optune, his tumor, which once was roughly the size of a tennis 
ball, had shrunk by about 60 percent to the size of a ping pong ball.
“Justin has had a pretty amazing response,” says Ney. “This is a rare op-
portunity and responsibility to touch lives in a unique way. We may not 
be able to change the outcome, but we can give patients more time, a 
better quality of life and that is astounding. That is what we strive to do.”
The	Future
While he and his mother have found solace in both meditation and 
humor, both confess they have “fall apart” moments, which can mean 
anything from nonstop crying to midnight binges on mac and cheese.
“The one that hit me hardest is grandchildren,” Brandy says. “He wanted 
children, I wanted grandchildren to spoil. Now, that may not be a pos-
sibility.”
For now, the Boley family focuses on living in the present, celebrat-
ing victories like a great MRI scan. They base their future plans on test 
results. Brandy confesses she is planning a 24th birthday party for Justin, 
ever mindful that with Optune they are only buying time.
“That’s what I’m hoping for,” Justin says. “Time. Because the alternative is 

















Fighting Back After Cancer Diagnosis
Physicist Rebecca Marsh's advice: Listen to your loved ones
By Tyler Smith 
Rebecca Marsh knows how to balance risk and benefit. 
A PhD physicist by training, Marsh spends a portion of her time at 
University of Colorado Hospital’s Breast Center clinics making sure the 
imaging equipment is working properly and delivering the appropri-
ate radiation dose. She also speaks with women, in person and on the 
phone, who are concerned that the radiation they receive from mammo-
grams, CT scans and other imaging tests will endanger their health and 
even possibly cause cancer.
Marsh, an assistant professor of radiology at the University of Colorado 
School of Medicine, does her best to counter their fears with facts. 
Despite splashy news media reports, there is no evidence that radiation 
from imaging equipment causes cancer. 
“I understand their concerns,” she says. “But there is a lot of false infor-
mation and I strive to send a consistent message that is accurate, acces-
sible and consistent.” For women considering breast cancer screenings, 
Marsh adds, “My job is not to convince them to get a mammogram but 
rather to help them make an informed decision.”
Such risk-reward calculations are the stuff of everyday life. But some-
times the odds break the wrong way. In March of last year, Marsh felt 
what she describes as “a structure” in her left breast. Although her 
mother had died at 57 from a rare abdominal cancer, there was no his-
tory of breast cancer in her family, and Marsh was only 36 – well below 
the American Cancer Society’s guidelines for a screening. 
She mentioned it during her next regular visit with her primary care 
physician (PCP) at a UCH clinic. You don’t meet the criteria for a clinical 
breast cancer exam, her PCP said. But a medical student was observing 
the visit, so the PCP took the opportunity to demonstrate how to con-
duct the exam. Everything seems fine, the PCP said, calling the structure 
the result of normal fibrotic changes.
“That coincided with what I had read online,” Marsh recalls as she sat 
in her tiny interior office in Research Complex 2 nearly a year later. “I 
wasn’t worried.”
Sudden	surprise
But someone else was. In November, Marsh’s boyfriend told her he was 
concerned about the small mass. It doesn’t feel right to me, he said. She 
played down his worry and laid out her logic: She wasn’t considered 
high risk for breast cancer, her PCP had told her there was nothing to 
worry about, she had lots of responsibility in her job with CU’s Depart-
ment of Radiology, and she felt fine. 
Her boyfriend held firm. I think this is different, he said. 
“I told him, ‘If it will make you feel better, I’ll get it checked out,’” Marsh 
says.
Shortly thereafter, she was in the mammography area of the Breast Cen-
ter in the Anschutz Outpatient Pavilion. She pulled a tech aside, related 
the background of the suspicious structure and asked for a recommenda-
tion. The tech told her the clinic takes walk-in patients, so why not get a 
mammogram? 
Marsh did so, and the image showed a mass that on first review looked 
like a cyst. She then got a follow-up ultrasound. A fellow radiologist 
came in the room and delivered bad news. The mass he saw had dif-
ferent shades. That meant it was probably not a cyst, which would be 
filled with fluid and therefore would show up as an image with uniform 
brightness.
It was now early afternoon, and Marsh headed in for a biopsy, which 
confirmed a 3-centimeter primary tumor. Her boyfriend and the tech 
who had done the mammogram stood by as Marsh asked the radiologist 
a blunt question: What’s your feeling about what’s going on? She got a 
numbing answer. The chances are 99 percent that it’s cancer, the radiolo-
gist said. That’s going to mean chemo, surgery and radiation.  
A	life	detour
“In the space of four or five hours, I went from thinking the worst-case 
scenario was that I had a cyst to ‘you very likely have cancer,’” Marsh 
says. Twenty-four hours later, the 1 percent chance she’d hoped for 
vanished. The pathology results showed two primary masses, both posi-
tive. Marsh had an aggressive cancer that most commonly shows up in 
women under the age of 40.  
 
The next big question – and potential ray of hope – was whether the 
cancer had metastasized. She emailed University of Colorado Cancer 
Center medical oncologist Virginia Borges, MD, for guidance. At Borges’ 
recommendation, Marsh got nuclear medicine and CT scans the same 
week and found her silver lining. There were cancer cells in several 
lymph nodes, but no evidence that the malignancy had spread to other 
parts of her body. A subsequent test showed no known genetic biomark-
ers, further decreasing the likelihood of a secondary cancer, particularly 
ovarian. 
Marsh began a regimen of eight chemotherapy treatments for Stage 3C 
breast cancer on Dec. 17, 2015, and completed the fifth Feb. 11. She’ll 
finish chemo at the end of March, and then have a four-week recovery 
period before her surgery – a lumpectomy, not a mastectomy, because of 
the specifics of her genetic testing and the size and location of the tumor. 
A six-week round of radiation is slated to begin the end of May.
She has a path forward, but her life with cancer follows no straight lines. 
Bad news is mixed with good, fear with hope. For example, cancer cells 
tend to be more aggressive in women under 40, but they also are often 
ideal targets for chemotherapy precisely because the tumors are grow-
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ing rapidly. Marsh 
deals with fatigue, 
illness, and mental 
lapses caused by the 
chemo, but that’s 
been cushioned a 
bit by 10 weeks 
of leave she had 
piled up. With her 
department’s strong 
support, she keeps 
a flexible work 
schedule.
Kid	stuff
The lines of life are 
the most blurred 
when it comes to her young children – Owen, 8, and Lucia, 5. One 
thought emerged from the confused swirl the day she confronted cancer: 
What am I going to tell the kids? She called her three sisters and ex-hus-
band to give them the news, then waited for her children to come home 
from school. Marsh told them she was sick, waited for their questions, 
and got the big one in about a minute: Are you going to die?
Her disease isn’t black and white, and neither was her answer. “The goal 
is no,” Marsh told them. “I said there are plenty of people with the same 
illness I have and many of them get treatment and live a long time.” See-
ing her son’s concern, she talked about what would happen as she went 
through treatment.
“I told them about the long-term plan,” Marsh says, “and that I was 
going to get medicine that would kill the cancer cells but that it would 
make me feel sick and tired and that my hair would fall out.” They went 
out together to pick out head scarves. When her son worried about 
people making fun of her for losing her hair, Marsh gave him a simple 
reply: “Tell them, ‘My mom is sick,’” she advised. 
When Marsh’s hair began to fall out after she started chemotherapy, her 
daughter asked, “Why would you take medicine that makes your hair 
fall out?” Marsh explained that she could either take the medicine that 
kills the tumor cells and wait for her hair to grow back, or keep her hair 
but let the tumor cells spread to the rest of her body.
“I think you made the right choice,” her daughter replied.
Rather than hide her periodic lapses in mental focus, she lets them know 
it’s something that comes with the chemotherapy. On one such occasion 
her daughter said, “You did that because of the medicine,” a line that has 
become something of an inside joke.
One	step	at	a	time
Marsh also tries to be pragmatic about the cancer and the limitations it 
has imposed on her life. She accepts that there are days the chemo will 
leave her physically sapped. “My perspective now is that when I’m not 
feeling well, I just have to wait it out.” She takes advantage of the good 
days and works as much as she can. She’s now preparing a presentation 
of her research for a March meeting in Salt Lake City and has made it a 
goal to make that trip.
“Because of the chemo, I’ve had to pull back on other professional in-
volvements,” she says. “I need this one thing I know I can do.”
Marsh still knows the importance of balancing risk and benefit. But her 
cancer has also given her a new perspective on the limits of knowledge. 
She trained at MD Anderson Cancer Center and spent nine years there. 
She did graduate work in radiation therapy physics. But cancer pays no 
attention to such qualifications.
“Cancer treatment is not foreign to me,” she says. “But there is a false 
impression that ‘smart’ people can catch cancer early. I’ve worked in 
mammography, and part of my profession is working with breast imag-
ing. I have a master’s and a PhD – and I still had stage 3C breast cancer.”
Marsh’s “public service message,” as she puts it, is simple. “If you notice 
changes and have concerns and suspicions, go in and check it out – even 
if it hasn’t been a year, or you’re too young, or you’re not in a high-risk 
category. Women in their 30s and early 40s are really busy, and it’s easy 
to put a mammogram off. But figure out a way to fit it in.” 
And listen to your loved ones, she says. “If my boyfriend hadn’t said 
anything, I might not have gone in for months,” Marsh says. “That might 
have made a big difference in how this all played out.” 
This article originally appeared in the UCHealth Insider in February 2016.


















CU to provide medical care at Greenland’s  
Summit Station
By Chris Casey
The University of Colorado School of Medicine’s De-
partment of Emergency Medicine is taking its expertise 
in austere medical care to one of the most extreme 
and remote places on Earth: Summit Station, a global 
research facility perched at 10,500 feet atop the Green-
land ice sheet.
In December, the department’s Wilderness and Environmental Section 
(WEM) won a subcontract grant from the U.S. National Science Founda-
tion to provide field health care services at Summit Station.
Jay Lemery, MD, associate professor of emergency medicine and section 
chief of WEM, says providing medical services at Summit Station allows 
WEM to “think outside the box” in an unpredictable environment.
“It’s basically the art and science of taking care of people in remote and 
extreme environments,” he says. “It forces us to think in very creative 
ways. How do we take 21st century medicine and apply what we know 
to these places where you don’t have the technological tools to do what 
we do on the CU Anschutz Medical Campus?”
WEM honed its expertise in remote medical services by holding the EMS 
medical directorship for the U.S. Antarctic Program for two years. In 
Greenland, the CU WEM bid was selected over other applicants, includ-
ing from private industry, for the subcontract, which lasts for a year 
with an option for renewal. WEM will work with CH2M Hill, the prime 
contractor, and Polar Field Services, a subcontractor providing science 
support and field operations.
Four	services	for	Summit	Station
In Greenland, WEM will be in charge of four phases of service:
• Remote medical support services and supplies for Summit Station;
• 24/7 telemedicine services;
• First aid medical support services; and
• Training in arctic first aid and wilderness first responder/aid.
Lemery notes that people are more frequently venturing to extreme 
places across the globe, and the expertise of WEM faculty – in altitude 
sickness, frostbite, hypothermia, trauma treatment and other wilder-
ness care – uniquely positions WEM to serve these travelers, as well as 
advance remote-setting health care.
“We have that niche in the health-care world,” Lemery says. “Greenland 
is a robust place to test best practices in medicine – to see what works, 
what doesn’t work. We’re also training people to be outstanding clini-
cians anywhere in the world. Most of the planet doesn’t have the medical 
tools like we have at CU Anschutz. These are important lessons to bring 
home to our students and residents.”
David Twillman, RN, University of Colorado Hospital, will staff Summit 
Station during the high season of roughly April to August. During the 
winter months, WEM will provide medical services via telemedicine.
‘Quite	a	bit	of	altitude	sickness’
Christopher Davis, MD, assistant professor of emergency medicine, led 
WEM’s application for the Greenland subcontract and will serve as medi-
cal director for the operation. He says adjusting to high altitude is the 
most common health complaint of the researchers, who spend weeks to 
months at a time at Summit Station. “Most researchers are coming from 
sea level and they fly directly to 11,000 feet,” he says, “so you see quite a 
bit of altitude illness.”
Davis, who is also medical director of Altitude and Mountain Medicine 
Consultants, a branch of the Travel, Expedition and Altitude Medicine 
Clinic, plans to visit the Summit Station this spring to ensure that the 
medical equipment is up to date. During the summer high season, about 
50 researchers live and work at the station. In the winter, fewer than 10 
people live at the facility, Davis says. Much of the research conducted at 
the facility focuses on climate and weather.
Greenland’s polar environment and growing medical needs made Sum-
mit Station a perfect fit for WEM’s service-oriented approach to health 
care.
“Our department chair, Richard Zane, MD, has been very supportive of 
us being entrepreneurial and extending the reach of our medical exper-
tise to far afield,” Davis says. “This is also in line with the university’s 
research mandate.”
Although no specific CU School of Medicine Greenland-based research 
has yet been approved, Davis says, “there will be the opportunity for us 
to study altitude and also study health care systems and how and wheth-
er telemedicine support is effective in this type of extreme environment.”
Unprecedented	course
Another opportunity that Summit Station provides: Teaching an un-
precedented course in one of the most dramatic locations on the planet. 
Lemery and Davis together will teach “Introduction to Polar Medicine” 
over a week in August in the town of Ilulissat, Greenland. Students will 
receive three hours of credit for the accredited course, as well as a Wil-
derness First Aid certificate.
“We’ll talk about climate change and health and provide wilderness med-
icine education,” says Lemery, who co-edited the book Global Climate 
Change and Human Health. “It’s pretty unorthodox – nobody’s really done 
anything else like this. We think it’s going to be an awesome opportunity 
for students.”





The nation's first interprofessional master’s degree in palliative care 
By Tonia Twichell
The nation’s healthcare providers 
are ill-prepared for the oncoming 
“silver tsunami” - 75 million baby 
boomers entering their senior years 
needing individualized care and 
help making medical decisions, 
says CU professor Amos Bailey, 
MD.
“Workforce estimates suggest that we will need 
10,000 to 15,000 providers to meet demand 
for palliative care services,” Bailey says. “Medi-
cal fellowship programs train about 300 fellows 
a year and graduate nursing programs are edu-
cating a similar number. We’ll never get there 
through that route.”
Bailey, who came to Colorado in 2014 after 
two decades in palliative care at the University 
of Alabama Birmingham, met with Anschutz 
Medical Campus leaders to create and fund the 
nation’s first interprofessional master of science 
in palliative care degree for physicians, phar-
macists, nurses and physician assistants.
Designed by the CU Graduate School for the 
mid-career provider, the first cohort of about 
25 students starts this fall. The Interprofes-
sional Master of Science in Palliative Care 
will prepare providers to become Palliative 
Care Community Specialists and focuses on 
advancing clinical knowledge, using evidence 
in building palliative care practice and com-
munication skills. An Interprofessional Pallia-
tive Care Certificate will also be available by 
completing the first 12 credit hours.
Palliative care helps patients with serious or 
life-limiting illness and their caregivers, and 
can help ease pain and other symptoms, as well 
as psychosocial and spiritual distress.
“All clinicians who care for those with serious 
illness should have a basic level of knowl-
edge of palliative care,” says Jean Kutner, MD, 
MSPH, chief medical officer of University of 
Colorado Hospital and founder of CU’s Pallia-
tive Care Program. 
Research shows palliative care can extend life 
and reduce pain and depression, says Kutner, 
former president of the American Academy of 
Hospice and Palliative Medicine. Medicare and 
Medicaid now cover patient-doctor conversa-
tions about end-of-life care, and the U.S. De-
partment of Veterans Affairs allows hospice care 
in conjunction with disease treatments, such as 
chemotherapy, Bailey says.
“We’ve known for 20 years that most people 
say that if they had a terminal illness they 
would want to be cared for at home. But we 
also know that the number of people who die 
in hospitals or some other institutional setting 
has not decreased in the last 20 years,” he says. 
“Providing people and families with options 
and expertise so they can understand their 
preferences and options when suffering from 
life-limiting illness can be a really hard thing 
to do.”
Julie Berk, MS, a physician assistant at Kaiser 
Permanente who graduated from CU Child 
Health Associate/Physician Assistant Program, 
plans to join the first cohort. Like many provid-
ers, she learned about palliative care on the job.
“One area of satisfaction I’ve had in my career 
is being able to sit with families and be hon-
est about their case, encouraging them to 
be thoughtful about health care decisions,” 
says Berk, who has worked in neurology and 
neurosurgery units. “Some physicians just want 
to treat and treat without a discussion whether 
continuing is harmful to the patient. We need 
to ask what is best for quality of life.”
Bailey’s path from oncology to palliative care 
came about serendipitously in 1989 when a 
nurse and social worker in his West Virginia 
practice asked him to be the medical director 
of a hospice program.
“They said ‘You won’t have to do much. Maybe 
prescribe something from time to time, but 
we’ll be running this.’” 
Within a few months a patient requested a 
home doctor visit.
“I was nervous,” he says. “I had no training in 
palliative care or pain management. I found the 
experience to be very epiphanal. That patient 
who I would usually have seen in a hospital 
could be so much more comfortable at home, 
and she talked not only about physical symp-
toms but about her own emotional, spiritual 
and psychological concerns. I was hooked.”
The master’s degree program will offer remote 
and on-site learning to practitioners around the 
country and will include instruction in the first 
two levels of palliative care starting with pain 
management and goals of care. Students will 
be linked to tertiary care experts, who provide 
care for the most complex cases.
Bailey would like to expand the program to 
include a master’s degree program for students 
from non-medical fields of spiritual care, psy-
chology, communications and social work.
Kutner hopes the master’s degree will encour-
age graduates to become leaders in their fields 
– regardless of their position or profession.
“I hope they become the champions in their 
own organization,” she says. 
Berk says palliative care education will change   
her own career and the future of medicine. 
“It’s much more difficult to die now because of 
advances in medical care, but that’s so senseless 
when it comes to quality of life. Quality has to 
be answered differently by different people, and 
that’s where medical professionals with training 
can help explore the question.”


















Preparing for an Emergency
CU medical students practice how to handle  
a public health crisis
By Chris Casey
A dangerous virus wasn’t the only thing quickly 
spreading when an outbreak of avian flu swamped the 
hospitals and clinics of Mountain City and High Plains 
City. 
Tension sometimes flared as public health officials responded to the cri-
sis. Stress often centered around dissemination of accurate information, 
so as not to touch off undue panic about the pandemic. 
It was all part of a March 2015 preparedness drill on the CU Anschutz 
Medical Campus – an annual tabletop exercise in the Integrated Clini-
cians Course for University of Colorado School of Medicine students. 
Two fictional cities in Colorado were dealing with the “outbreak,” and 
the responders were about 150 fourth-year students representing all 
disciplines within the School. Leading each student team were actual 
professionals representing health agencies, cities, hospitals, clinics and 
the media. 
‘Critical	decisions’	
Students went into the exercise knowing only they’d face a health crisis 
of some kind. “This tabletop is going to cram a pandemic of six to eight 
weeks … into about 90 minutes,” said Charlie Little, DO, associate pro-
fessor of emergency medicine. 
“There are really no right or wrong answers,” Little told the group before 
students broke into 16 teams representing health agencies, city and state 
offices, hospitals and clinics, media and an ethics group. “It’s designed to 
help you work cooperatively in a group. The key thing is you’re going to 
have to make critical decisions with limited information, and that’s what 
happens in emergency management.”
A key part of the exercise was seeing how public health emergency 
response unfolds and how various agencies coordinate to best manage 
a crisis, Little said. “The goal is to have the students work through the 
issues under time pressure like they would in a real-life event,” he said. 
“That usually gets them a little stressed.” 
Metro News, the media outlet in the drill, became a source of irritation 
for a few agencies and government offices scrambling to contain the pan-
demic as well as release timely and accurate information to the public. 
‘A	difficult	balance’
Tyler Anderson, a fourth-year student specializing in psychiatry, volun-
teered to be editor of Metro News. He enjoyed the exercise, but found it 
quite challenging. “It’s kind of a difficult balance” to be both quick and 
accurate in news reports, he said. “I understood better the reporters’ 
need for information – like why they push so hard and why it can be an-
noying to people. But it really helps get information to the public.”
At one point, as Metro News reporters fanned out to press for informa-
tion, a hospital representative stepped into the “newsroom” and threat-
ened to sue the outlet for an alleged libelous tweet. Metro News stood by 
its story.    
Anderson said the drill brought to light some comforting insights as 
well, such as learning about actual strategic medication supplies. “We as 
medical students aren’t the only ones being trained in what emergency 
response looks like,” he said. “It’s something that’s being thought about 
at many levels – city and national government, as well as public health 
agencies. It’s good to know that it’s being considered and thought about, 
so something won’t hit us completely off guard.”
Shilo Smith, a fourth-year student specializing in neurology, said she has 
received incident-command training and knows just how quickly things 
can come unglued in an emergency. “I can tell you it is a challenge to 
make sure that people have the supplies they need,” she says.
Jeffrey Druck, MD, associate professor of emergency medicine and direc-
tor of the Integrated Clinicians Course, spoke to the full group at the ex-
ercise debriefing. Students said the fast-paced drill was at times stressful, 
but also informative as to the enormous coordination required to manage 
a public health emergency.
“We hope this brings home to you how important it is to get involved in 
disaster planning early as opposed to later,” Druck said. “As you can see 
from this exercise, if you are behind the eight ball it can be much worse 
than if you are in front of the eight ball.”
 COMMUNITY 15
Opening Lab Doors 
Gates Center hosts high school students
By Chris Casey
Eyes widened among the high school students when 
Neil Box, PhD, an assistant professor of dermatology 
in the University of Colorado School of Medicine, held 
up ultraviolet (UV) images of faces – their faces – that 
showed sunburn damage lurking under the surface of 
their skin.
A lot of dark splotches indicated a 
history of intense sun exposure to 
the skin. Faces with few splotches 
indicated that the student has prac-
ticed good sun safety – i.e. faithfully 
applying sunscreen.
Twenty-two high schoolers from the 
Career Education Center (CEC), 
a high school in Denver Public 
Schools, visited the University of 
Colorado Anschutz Medical Cam-
pus in February for a shadow day 
that offered close-up insight into 
research and healthcare-related fields. A group of 20 other CEC students 
enjoyed a CU Anschutz field trip earlier in the month.
Box and Tamara Terzian, PhD, who are investigators in the Gates Center 
for Regenerative Medicine and the CU Cancer Center, along with sup-
port from Christian Valtierra, assistant director in the Office of Inclusion 
and Outreach, led the tours on both occasions.
‘Genuine	sense’	of	lab	work
Before the students broke into two groups – touring separately, each 
group visited the Box and Terzian melanoma research labs in Research 
1 North as well as the Gates Center for Regenerative Medicine– Box 
explained that they would see actual cutting-edge research being per-
formed. “We want to give you a genuine sense of what it’s like to work 
in a research lab,” he said. “A lot of the things you are going to see today 
have provided the evidence basis for the current standard of practice in 
much of the health care field.”
One of the students, Jose, said he had no idea that this level of research 
took place at CU Anschutz. “I just thought it was a normal school on this 
campus,” he said. “I like how they look at your DNA and try to figure 
out if you have any diseases.”
He was in the group that made its first stop in the DNA extraction and 
UV activity laboratory. The students donned lab coats then learned how 
to perform their own cheek swab. They each 
produced a research-ready DNA sample and had 
their facial picture taken by the UV imager.
Subjects for a current Box-led study into molec-
ular signatures of lifetime UV exposure went through a similar process. 
The research has determined which genes are involved in predisposing a 
person to skin disease, such as melanoma. “Your history of sun exposure 
and your DNA determines your damage score (or predisposition level),” 
Box said. “What the students are seeing here for their career experience 
is within the context of our real, ongoing research. This study isn’t even 
published yet. We’re working on the analysis and getting it finalized for 
publication right now.”
‘This	experience	is	relevant’
The CEC students are in a biomedical class and recently completed a 
unit on DNA, including extraction of DNA from a strawberry. But the 
CU Anschutz tour took their understanding of genetic coding to another 
level – a very visual level.
“Health care careers hinge on what goes on in the research lab, so we 
think having this experience is relevant to them in a lot of ways,” said 
Box, who also gave a speech at CEC. “Hopefully, today’s shadow day will 
inform them when it comes to making their own career decisions.
“Also, by coupling the research with our sun safety message, we hope to 
inform them about good, healthy behaviors,” he said.
Jose said the tour was “cool” as well as eye-opening. “I’m interested in 
doing autopsies and forensic research,” he said.
Above, Denver high school students checked the 
level of sunburn damage on their faces during a 
visit to the Anschutz Medical Campus. Left, Tamara 


















“Work Hard and Enjoy Your Life Along the Way”
Astronaut Kjell Lindgren visits Anschutz Medical Campus 
By Steven Barcus
Kjell Lindgren, MD ’02, has wanted to be an astronaut 
as long as he can remember. That dream became a re-
ality in July 2015 when he blasted off from Kazakhstan 
in July as part of NASA’s Expedition 44/Expedition 45 
to the International Space Station (ISS). During his 
141 day mission, Lindgren completed two space walks 
and conducted experiments in physics, life sciences 
and fuel combustion.
“That was one short amazing leg of a really 
extraordinary journey,” Lindgren told a group 
of students during a visit to CU Anschutz in 
March. “I spent a good deal of my journey at 
CU. That journey took me to NASA for two 
and a half years of training to be an astronaut, 
with two years of mission specific training 
for this mission, and then to Kazakhstan for 
launch.”
Changing	the	map
Lindgren’s journey to space has been decades in the making. However 
becoming a doctor was not originally a part of his plan.
Fascinated with space, Lindgren had read “The Right Stuff” and Chuck 
Yeager’s biography — using those books to create a map he could use 
to become an astronaut. That map told him he needed to become a 
test pilot. At age 11 he sent off for materials to apply for the Air Force 
Academy. He never got a response, but that did not deter Lindgren from 
his dream.
Lindgren continued to follow his map. He was eventually accepted into 
the Air Force Academy and was awarded a pilot slot, which Lindgren 
deferred to study at Colorado State University. After returning for pilot 
training, Lindgren, who describes his journey in terms of peaks and val-
leys, was diagnosed with a medical condition that not only washed him 
out of pilot training, but also the Air Force.
“That was pretty significant valley,” Lindgren said. “I wallowed in 
that for a little bit, but then I reworked my map and began climb-
ing out of that 
valley.”
Lindgren’s new 
map brought him 
to the Univer-
sity of Colorado, 
where he earned 
his MD in 2002.
“I had the great 
fortune to study 
here at CU,” 
Lindgren said. “I 
am profoundly 
grateful to be 
back on the CU 
campus. This is 
where I did my 
medical training. 
It was a significant 
and very impor-
tant part of my 
career. It feels like 
I am coming full 
circle to be back 




Lindgren spoke with students about his own experience at CU, recall-
ing long nights memorizing the names of bones, muscles and nerves for 
Gross Anatomy. He and his peers would sit in a classroom with a skel-
Photos by Trevr Merchant. 
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eton going from top to bottom, over and over, naming everything until 
they had memorized it to perfection.
“Whatever you’re doing you have to be a nerd in it, so we became 
anatomy nerds,” Lindgren said. “You have to bring it.”
It was not just Lindgren’s incredible work ethic that saw him through his 
medical training. He also employed outside-the-box methods to succeed. 
To ensure he would do well on a test identifying anatomy of cadavers, 
Lindgren analyzed answers from tests given in previous years into a his-
togram and frequency distribution, allowing him to see the answers most 
frequently sought on exams.
The work yet again paid off. Lindgren’s unorthodox test preparation 
showed that the thoracic duct appeared on most of the practicals. During 
the test, when he saw a pin placed in an unknown area of the cadaver, he 
made the assumption that it must be the thoracic duct. He was right.
“Work hard and enjoy your life along the way,” Lindgren said. “I’m grate-
ful for my path. Even though I slipped into several valleys I was always 
able to climb my way out.”
Lindgren went on to become board certified in emergency medicine and 
aerospace medicine, before he was selected by NASA in 2009 to become 
an astronaut. To become one of the nine selected for training, Lindgren 
rose to top of a pool of 3,565 initial applicants — of which only 113 
received an interview and only 48 became finalists.
‘An	indescribable	experience’
While Lindgren’s medical training helped him stand out among other 
applicants, his primary role during the mission was not as a physician. 
According to Lindgren, a physician is not always included on every flight 
as all astronauts are trained across all equipment, duties and responsibili-
ties.
“Whether you are a test pilot, infectious disease researcher or a physi-
cian, we all get trained the same level on all of the equipment,” Lindgren 
said. “We can all repair equipment, do a spacewalk and respond to 
emergencies.”
Lindgren assisted in a variety of studies while aboard the ISS. Some of 
the research conducted included understanding how flames propagate 
and how fuel moves within a tank in space. He and his fellow astronauts 
also grew and ate lettuce—becoming the first astronauts to grow and 
consume a crop in space.
Perhaps the most significant moments for Lindgren were spent during 
his two spacewalks, each of which lasted more than seven hours.
Achieving his dream of becoming an astronaut has not left Lindgren 
without purpose. Since returning to Earth, he has been speaking with 
the public about his experiences in space and is looking forward to ana-
lyzing data from his experiments in space and helping to train the next 
group of astronauts. Lindgren is open to a return trip to the ISS, but in 
the meantime is enjoying discussing his journey.
“There is no one path to becoming an astronaut,” Lindgren said. “That’s 
demonstrated in my career. Find a place where you are passionate and 
work to get to the top of your field. If you study what you think NASA 
wants you to study and you don’t like it, you won’t succeed. Choose 
what you have a passion for.”
NASA astronaut and CU School of Medicine alumus Kjell Lindgren (center) 

















Being a Good Neighbor
Hire Local program helping to build a campus work force
By Tonia Twichell
Victoria Browning and the Anschutz Medical Campus 
grew up side by side in Aurora. But once Browning 
graduated high school and began working in health 
care, the two seemed destined for separate paths.
“I applied for several jobs on campus, but it was mission impossible,” 
says Browning, who has a background in medical assistance, lab work 
and nursing home care.
Browning’s struggle to land a job on campus ended when she entered the 
Hire Local program through the Community Campus Partnership (CCP), 
an organization funded by the University of Colorado and The Denver 
Foundation since 2013 to create links between the campus community 
and surrounding low-income neighborhoods.
One of several CCP missions, Hire Local began last year with a pilot 
project funded by a grant from the Colorado Department of Education 
to the Community College of Aurora. Entitled the Healthcare Bridge 
Program, the pilot enables CCP to partner with the college and both 
hospitals on campus to educate local students for jobs. 
Since last spring, four cohorts have graduated in two entry-level fields of 
customer service and sterile processing, both high-turnover positions at 
University of Colorado Hospital and Children’s Hospital Colorado. 
“We want to make the campus look more like the surrounding neighbor-
hoods,” says CCP Director Robert McGranaghan, MPH, senior instructor 
in the Department of Family Medicine. “It is 
important to think about investing in pro-
grams that will result in improved well-
being, health, wellness and diversity.”
The students go through 10 weeks of 
training that include classes in inter-
viewing, resume building, computer 
skills and job readiness. 
Many graduates would have had a 
hard time finding work without Hire 
Local, McGranaghan says. Some are 
immigrants who are unfamiliar 
with local hiring processes. 
Others have been out of the 
workforce a long time. 
“Some folks have 
not completed high 
school,” he says. “We had a student in her 50s in the first cohort who 
had never touched a computer.”
Just as Hire Local was starting up, CCP invited campus employers to 
meet with community members to talk about obstacles to campus em-
ployment.
“We learned there were a lot of barriers,” says Lisa Jensen, BSN, the part-
nership’s campus connections program director. “(Community members) 
weren’t sure what entities exist on campus. They had no idea how to 
get a job in a hospital. Some had applied continuously and never got a 
response. Some were not even sure they were allowed on campus. 
“And what was clear is that they didn’t just want a job. They wanted to 
contribute. They felt their skills and knowledge would help the hospitals 
deliver better care because they would be able to communicate with 
people like themselves.”
At the end of the summit, campus employers began working with CCP 
to find ways to smooth the path for local applications.
Hire Local has been so successful that CCP leaders plan to expand the 
program to include more careers for local residents including certified 
nursing assistant, medical assistant and medical coder.
“We want stackable jobs – entry-level jobs with a career path,” Mc-
Granaghan says. “This is not a social service, this is a market service to 
help fill (campus employer) needs in high turnover jobs. “
Other CCP projects in the pipeline include:
• Buy Local: CCP is meeting with small businesses and enterprises 
to help residents including immigrants and refugees provide goods 
and services for the campus. 
• Job hub: CCP plans to open an office in a central Aurora loca-
tion where residents can learn about jobs on and off campus. CCP 
would also offer assistance on how to keep a job and advance in an 
organization. 
All these efforts are intended to help the campus be a good neighbor to 
communities that rank amongst the state’s poorest, McGranaghan says.
“You can make the argument that if you employ people who live locally, 
they are arguably more likely to keep their job,” he says. “High turnover 
rates may decrease if they get the support they need. We’re working to 
ensure retention.”
Browning, who has worked since November as a patient access represen-
tative in the CU Department of Medicine's Division of Internal Medicine, 
is hoping for a future at UCH.
“I feel like there’s so much room for growth,” Browning says. “And oh my 
goodness, it literally takes only 10 to 15 minutes to get to work.” 
Victoria Browning. Photo 
by Trevr Merchant. 
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Power Punch
Physical therapists treating patients with non-contact boxing classes
By Derya Anderson
At first it would seem that boxing and Parkinson’s 
disease don’t have a lot in common. However, if you 
ask physical therapist Lee Chow, he would tell you 
differently.
Chow, DPT, is one of the coordinators of the Power Punch for Parkin-
son’s program, a class held at local boxing gyms and taught by boxing 
coaches and physical therapy students with the aim of providing a new 
and exciting exercise option for patients with Parkinson’s disease.




ficulty with balance. 
An ideal exercise 
regimen for this 
type of disorder 
would incorporate 
quick movements, 
weight shifting fluid 
motion and focus. 
These are charac-
teristics intrinsic to 
boxing, which also 
involves trunk and 
neck rotation, dual 
task activities and 
aerobic exercise, all 
of which are impor-
tant in the management of the 
effects of Parkinson’s disease.
Participants are also able 
to see progress, find social 
support and literally “fight” 
their disease, which keeps 
them coming back for more. 
Obviously, physical therapists 
couldn’t help but get involved 
with this amazing combina-
tion.
“It’s been great watching the program grow,” says Lee, who was intro-
duced to Power Punch during his second clinical rotation of Physical 
Therapy Program at the University of Colorado. He helped form the 
program in Denver and the first official Power Punch class was offered at 
the Cox-Lyle Red Shield Boxing gym in Denver in November 2014.
Since then, there have been new classes added there an at several other 
locations in Fort Collins, Boulder, Colorado Springs, Vail and other sites 
in Denver.
The program also provides an avenue for PT students to offer service 
in their communities and deepen their understanding of Parkinson’s 
disease.
Second-year PT student Rachel Powell says: “[The participants] all 
come to us in different stages of the disease and every single person is 
so inspiring. They challenge me to come up with different activities and 
I learn something new every 
class.”
Samantha Stolper, also a second-
year PT student, says: “Every 
person has a unique story and 
Parkinson’s disease is only a 
small part of that. It’s incredible 
to see their journey from when 
they first start boxing to when 
they become comfortable and 
fluent with the moves.”
Power Punch for Parkinson’s uses 
boxing techniques as physical 


















Medical Ethics and the Holocaust
Program explores how care providers lost their way
By Tonia Twichell
In 2013, the Liaison Committee for Medical Education 
polled all medical schools in North America to find 
out how many require students to learn about the role 
of physicians in the Holocaust.
The answer: 22 of 140, a dispiriting number to some University of 
Colorado faculty members who had requested the question be included 
in the annual survey. 
In a June 2015 letter to journal Academic Medicine, Matthew Wynia, 
MD, MPH, director for the CU Center for Bioethics and Humanities, 
William Silvers, MD, and Jeremy Lazarus, MD, wrote, “… it appears that 
the specific attention to arguably the most influential set of events in the 
history of professional ethics in medicine is required at only a fraction of 
U.S. and Canadian medical schools – and this despite a uniform require-
ment to teach ethics and professionalism.”
They knew there was interest in the subject. Silvers, who was involved 
in organizing a series of seminars on medicine and the Holocaust in the 
Denver area starting in 2008, says overflow crowds attended some of the 
presentations at Anschutz Medical Campus.
When Wynia came to CU three years ago, he and Silvers collaborated 
to continue the program on campus. In October 2015 Silvers pledged 
$100,000 to kick-start the CU Holocaust Genocide and Contemporary 
Bioethics program. All three physicians were involved in its creation. 
“I always felt a personal responsibility to not lose the lessons that should 
have been learned in the Holocaust,” says Silvers, whose parents were 
survivors of the camps. His mother was liberated from Auschwitz, his 
father from Dachau. “I especially felt strongly about the role of medicine 
since I am in medicine.”
Wynia became involved in Holocaust education while working as the 
director of the Institute of Ethics at the American Medical Association 
and was asked by the US Holocaust Memorial Museum to collaborate 
on a program around the museum’s Deadly Medicine: Creating the Master 
Race exhibit.
“I have an interest and a passion to better understand physicians who 
become killers,” Wynia says. “What is the path to evil? These are people 
who are sworn to uphold human dignity and to pursue the well-being 
of people they take care of. Despite that, they become entirely perverted. 
What’s more, there are research abuses that take place in the U.S. Why is 
it that it doesn’t become widespread?” 
The program’s seminars will incorporate other historic genocides as well 
as more recent abuses like the Tuskegee syphilis study (1932-72) and 
health professional involvement in prisoner torture in Abu Ghraib and 
elsewhere. But the clearest example of medical complicity in genocide 
is the Holocaust, which Silvers calls the “sentinel genocide of Western 
society for our generation.” 
“In almost every arena of medical ethics there is some feature or often 
the core that was influenced by the Holocaust,” Wynia says. “All of the 
big issues today and the way we think about them are influenced by this 
history. It’s distressing not having this information included as part of a 
student’s education.”
Most people don’t know the extent of participation by health care profes-
sionals during the Nazi regime.
“What people know about medicine and the Holocaust usually extends 
to (German physician and SS captain Josef) Mengele and his medical re-
search abuses,” Wynia says. “His crimes aren’t the most important thing 
to understand. What Mengele did – that’s what happens after things have 
already gone way too far.” 
The physicians would like the seminar information eventually to be 
included in interdisciplinary courses on campus. 
Meanwhile, they will encourage students and campus professionals to at-
tend Holocaust program seminars to learn the relevance of the Holocaust 
in their own careers. Seminars in early May featured bioethicist and 
author Art Caplan, PhD.
“There were medical heroes in the camps, but not as many as you’d 
hope,” Wynia says. “Of all those people who performed ‘rampe’ duty at 
Auschwitz (the process of selecting who would live and who would go 
to the gas chambers), of all the doctors, nurses and dentists, just one 
person is known to have refused. A physician. And he was not punished. 
That leads one to wonder, ‘What if many had said no? What if the medi-
cal profession had stood up?’”
Silvers hopes students take the lessons to heart.
“I want them to have an appreciation of potential for human beings to 
do wrong and for medical professionals to have the moral compass to do 
right,” Silvers says.
ISWASWILLBE:	The	Holocaust	Series
Paintings by Geoffrey Laurence 
April 3 - Aug. 4  
Exhibit at the Fulginiti Pavilion Gallery on the Anschutz Medical Campus, 
co-sponsored by the Mizel Museum in Denver.
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Understanding Sex Differences Research
Regensteiner leads center to improve health care for women
By Lindsay Lennox and Jane Hoback
Judith Regensteiner, PhD, divides 
her roles into three areas at the CU 
School of Medicine: research, men-
toring and teaching.
As a professor of medicine, a founder and 
director of the Center for Women’s Health 
Research (CWHR), and the Judith and Joseph 
Wagner Chair in Women’s Health Research, she 
trains and mentors young scientists in women’s 
health and sex differences research, conducts 
research on diabetes and cardiovascular dis-
ease, and develops programs for the public and 
the medical community.
“Diabetes and cardiovascular disease are two of 
the most devastating disease areas for women,” 
says Regensteiner. “Importantly, diseases can 
present differently in women. Their symptoms, 
treatments and diagnoses could differ too.” 
She adds that women with heart disease have 
unique issues, and women with diabetes are 
more likely to experience adverse consequences 
of heart disease than men with diabetes. “There 
are very important scientific questions to be 
answered so we can treat both men and women 
effectively.”
Regensteiner’s current research focuses on the 
effects of diabetes on cardiovascular exercise 
capacity. She and collaborator Jane Reusch, 
MD, have found that exercise capacity can be 
impaired in people with type 2 diabetes. Their 
work in adults has led to work in adolescents 
with type 2 diabetes by pediatric endocrinolo-
gists specializing in diabetes in youth which 
showed similar findings.
A	‘lifespan	approach’	to	women’s	health
The CWHR takes what Regensteiner calls a 
“lifespan approach,” with researchers studying 
fetal programming, adolescent obesity, type 1 
and type 2 diabetes in youth, sex hormones in 
young women, and diabetes, osteoporosis and 
heart disease in middle-aged and older women. 
“Teens never used to get type 2 diabetes,” says 
Regensteiner. “But as lifestyles become more 
sedentary and overweight becomes more preva-
lent, they’re getting type 2 diabetes in increas-
ing numbers. That might even mean we’ll start 
to see younger and younger people having 
heart attacks.” 
Other projects sponsored by the CWHR 
include using behavior change techniques to 
increase physical activity to people with dia-
betes using technology in the clinical setting, 
understanding how the causes of obesity begin 
in the womb, and working with big data to 
study peripartum cardiomyopathy in women.
Closing	the	gap	in	women’s	health	
research
Established in 2004 to try to close the gap in 
knowledge about women’s health and sex dif-
ferences research, the CWHR today supports 
45 young MD and PhD scientists, primarily 
through seed grants awarded from the center in 
a peer review process. All types of science are 
included, ranging from basic science to clinical 
and translational research to epidemiology and 
big data. To date, the CWHR has provided 
approximately $1million in seed grants, help-
ing to leverage over $42 million in external 
funding, mostly from the National Institutes 
of Health. Additional sources of funding for 
junior faculty include the $2.5 million Building 
Interdisciplinary Research Careers in Women’s 
Health NIH K-12 grant, of which Regensteiner 
is PI, and the new Doris Duke Fund to Retain 
Clinical Scientists. 
In addition to its competitive grants, the 
CWHR mentors the next generation of scien-
tists and teaches them skills they will need as 
academics, including various aspects of career 
development, how to apply for a grant and 
how to give talks, not only to professional col-
leagues but also to the public.
Growth	in	the	community
When Regensteiner and the other founders 
started the center, they realized they couldn’t 
ask the university for all the money such an 
endeavor would require. Since its inception, 
the CWHR has had a strong community pres-
ence in the form of an extremely supportive 
community Advisory Board, which has also 
played a key role in raising money for the 
CWHR. In 2013, the CWHR’s first (and found-
ing) Advisory Board Chair, Judi Wagner and 
her husband, Joe, led efforts to endow one of 
the first chairs in women’s health research in 
the country, the Judith and Joseph Wagner 
Chair in Women’s Health Research, held by 
Regensteiner. The CWHR has just completed 
its second Chair, the Nancy Anschutz Chair 
in Women’s Health Research. “The role of the 
community in the CWHR’s development and 
evolution cannot be overstated and has played 
a huge role in the growth and culture of the 
center,” says Regensteiner.
As part of the CHWR’s community outreach, 
the center offers programs for the public, 
health care professionals and the academic 
community that feature experts from around 
the country speaking on a variety of topics. 
The center has partnered with University of 
Colorado Hospital for the successful “Let’s 
Talk” series, a public series of talks focused 
on presenting evidence- based information on 
important topics.
In the more than 10 years the center has 
been operating, Regensteiner has noticed a 
sea change in women’s health issues. “Other 
centers are starting to spring up across the 
country. I get contacted a lot by people who 
want to start women’s health research centers,” 
she says. “We’re learning new things. The field 
of women’s health research and sex difference 



















Family Medicine’s John Hill and his amazing adventures
By Todd Neff 
John C. Hill, DO, is a single human being, tall, lean, 
bald-shaven, and, on this morning in his south Denver 
home, wearing a belt with a silver buckle he earned 
by finishing the Leadville 100 Mountain Bike Race in 
under 12 hours. But he must have some cat in him, in 
his case, living nine lives all at once.
Hill has delivered a thousand babies, yet is somehow also a CU Sports 
Medicine subspecialist in an orthopedic musculoskeletal ultrasound 
technique he helped pioneer and applies to the injuries of many 
UCHealth patients. He’s an avid cyclist, with his stationary trainer 
perched in a corner of the family room and a carbon-fiber tandem bike 
he rides with wife Gail that hangs in a space adjacent to the garage. 
“It handles great,” he says, “Even going sixty or seventy down mountain 
passes.” 
He’s also an avid biker, having ridden all over the country on a series of 
Harleys, one of which he rebuilt more or less from the ground up. He 
has hosted booths at VeloSwap; he has hosted booths at the Colorado 
Motorcycle Expo. 
In 2013, Hill earned three patents for an approach to identifying glyco-
gen stores in muscle using ultrasound, which is best known for its ability 
to discern boy from girl inside a belly. The patents hang on the wall of 
the backyard treehouse he uses as his home office. He built the treehouse 
for his daughters 19 years ago, when they were three and five years old, 
and has had to replace its surrounding deck four times as the sugar 
maple further asserts its girth. The doors top out at his nose, but it’s got 
220-volt service, R-40 roof insulation and a programmable thermostat-
controlled heater. He built the treehouse using tools in a 1,000-square-
foot wood shop he also built, in which switching on the power band 
saw, drill press, lathe, thickness planer, joiner, table saw or router drops 
the amperage such that the dust collector turns on as if by magic.
At about 6:30 a.m. every other Saturday and Sunday during the winter, 
Hill slips skins over his skis and heads up Winter Park Mountain, assess-
ing the snow conditions during the hour-long climb. If it’s hard-packed, 
there will be broken wrists and dislocated shoulders; if soft, he antici-
pates blown knees and tibia-fibula fractures. He skis down and serves as 
an attending emergency medical physician at the base, where he tends to 
prove himself right. Last year, he restarted a guy’s heart four times with a 
defibrillator; three weeks later, the man walked in to thank him. Both of 
them had tears in their eyes.
The challenge with John Hill is grasping that a single 
human being could possibly manage to do all these 
things and more while staying happily married for 34 
years, raising two daughters, and narrowly escaping 
death by avalanche at 22,000 feet in Nepal along the 
way. It helps to start from the beginning. 
The beginning
Hill was born in Denver 59 years ago. His father, 
his father’s father, and his great-grandfather were 
all carpenters. Hill went to South High School, the 
University of Northern Colorado and Colorado State 
University, studying music theory and composition, 
speech pathology and audiology. He toyed with the 
idea of becoming a PhD neurophysiologist, but de-
cided he would follow the spirit of another carpenter 
and do missionary medicine in Africa. He earned his 
doctor of osteopathy at Western University of Health 
Sciences in Pomona, Calif., and headed for the Uni-
versity of Missouri at Kansas City, where he did his 
residency at Truman Medical Center-East.
He imagined what skills a doctor in the African 
John Hill, DO. Photo by Todd Neff. 
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hinterlands might need and learned 
them, doing surgeries, setting bones 
and delivering 300 babies by the 
time he wrapped up his residency in 
1990. He passed his Family Medicine 
boards and was all set to head to Africa when he and wife Gail adopted 
their two daughters. One turned out to have a medical condition that 
precluded overseas travel. 
So Hill worked in emergency rooms and did primary care in Missouri 
until 1994, when he and Gail, who grew up on a dairy farm in Fort 
Lupton, moved the family back home to Colorado. For years he was on 
call every second or third night delivering babies and doing C-sections, 
working with residents and helping in a training program for advanced 
obstetrical skills. Being an ultrasound expert came with the territory.
The transition
Meanwhile, he had long been a competitive cyclist, had run the Boston 
Marathon and had started doing triathlons. His interest in sports medi-
cine grew. 
“Virtually everybody in sports med is a beat-up athlete,” Hill says. “You 
try and figure out more and more how to keep yourself alive and doing 
stuff.”
So in addition to his work in obstetrics and as a family physician (his 
University of Colorado academic appointment was and is with the De-
partment of Family Medicine), he became more involved in the growing 
field of primary care sports medicine.
“It’s not just waiting until someone tears their ACL – it’s exercise physiol-
ogy, performance assessment and training, more in-depth rehabilitation, 
understanding the biomechanics, and a lot of emphasis on prehabilita-
tion,” Hill says.
By 1998, he had founded and was directing the CU School of Medi-
cine’s Primary Care Sports Medicine Fellowship, which he continues to 
do. Right around the same time, ultrasound manufacturers developed 
machines capable of imaging superficial tissues. Hill used it for guid-
ing needles toward breast cysts and thyroid glands. And then he took a 
resident along on a mountain bike ride, and the resident missed a corner 
and crashed. For six months Hill used the tool to watch a partial thick-
ness rotator cuff injury heal. When he presented the results at a confer-
ence, he said, “There was a total hush in the room. No one had ever seen 
anything like it.”
Hill helped pioneer musculoskeletal ultrasound, which every primary 
care sports medicine fellow in the United States is now required to learn, 
he says. It’s something like an MRI image, but one that allows the patient 
to move, thereby letting the physician observe how motion affects the 
injury. It works on ankles, knees, 
thumbs, hips, shoulders, wrists, 
elbows and more. It can help doctors 
set fractures more accurately and 
place needles in the one-millimeter 
space of the biceps tendon sheath. Trying to do that blind, Hill says, 
“the odds are like hitting the lottery.” More recently, Hill has been using 
a Tenex procedure to use ultrasound to both guide and repair tendon 
injuries causing tennis elbow, plantar fasciitis, and shoulder, patellar and 
Achilles tendon injuries. With all the sports medicine work, he’s tapered 
off his obstetric load.
Look at these muscles
He’s extended his ultrasound investigations from tendons to the muscles 
themselves – in particular, the amount of glycogen fuel resident in a 
muscle, information of great interest to endurance athletes and their 
nutritionists. He and Iñigo San Millán, PhD, CU Sports Medicine’s Exer-
cise Physiology Lab director, studied riders from the Garmin pro cycling 
team, and linked the flow of water in a muscle with that of glycogen. 
Comparisons with biopsies confirmed a strong correlation, and led to the 
patents hanging on his tree-house office wall.
Hill says he’s increasingly applying his sports medicine knowledge to 
his own body, which has endured repeated punishment courtesy of the 
Leadville Race Series – for which he has also served as medical direc-
tor. In the span of 50 days from June-August 2010, he completed the 
Leadville Trail Marathon, the Leadville Silver Rush 50-mile trail run, the 
Leadville Trail 100 mountain bike race, the Leadville 10K run, and the 
Leadville Trail 100 run, thereby becoming one of 17 that year to earn 
the title of “Leadman.” (He got a large belt buckle for this, for the cost 
of entry fees plus 54 hours, 57 minutes and 52 seconds of suffering at 
altitudes of up to 13,185 feet).
“I have a lot less energy and a lot more sanity than he does,” quips Gail.
Hill would have had it the previous year, too, but, running the entire 
Leadville Trail 100 on a cracked calcaneus (heel bone) slowed him 
down. He finished eight minutes after the 30-hour run’s cutoff. Rather 
than a belt buckle, Hill got three months on crutches.
He earned the belt buckle he’s wearing this February morning in the 
2015 mountain bike race, but he says he’s taking this summer off from 
Leadville, he says. 
“It’s hard to balance all of the different things,” Hill says. 
Though one does suspect that, as much as any single person might, he 
will find a way to fill the void.
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A recent gift of precious books to the CU School of 
Medicine by alumnus John Farrington, MD ’52, of-
fers a glimpse at just how far medical knowledge has 
advanced.
Last fall, Farrington donated five rare books, published between 1676 
and 1896, from his private collection to the School “that changed my 
life,” he says. 
One, an X-ray machine manual published in 1896, was handed down 
from Farrington’s father. Two other books — textbooks published in the 
19th century about diphtheria and human physiology — were given to 
Farrington by a former patient.
The other two texts, both published in 1676, came to Farrington from an 
elderly Irish neighbor named Thomas O’Shea.
“The two oldest books have a real history,” Farrington says. 
Farrington and O’Shea would sit on the front porch swing of his Boulder 
home, having conversations that opened young Farrington’s eyes to a 
wider world. But when Farrington was 8 years old, O’Shea moved to 
Florida to escape the Colorado winters. 
Before he left, the Irishman gave Farrington a gift: two human anatomy 
books by English physician Thomas Willis that O’Shea said he purchased 
at a market in Mexico City. 
Farrington kept 
the leather bound 
books in his child-
hood bedroom. In-
stead of traditional 
bedtime fables 
about witches and 
trolls, Farrington 
and his father spent 
time perusing the 
linen pages with its 
Latin script and en-
gravings describing 
detials like where in the human body the soul resided.  
After serving in the U.S. Army, Farrington — like his father and grandfa-
ther before him — became a physician. 
“I started as a medical student in 1948 with white knuckles because I got 
in as an alternate — I found out on a Friday that I was going to medical 
school on Monday,” Farrington says. “I was concerned because I wanted 
to do well. But the reality was that medical school was the easiest part of 
my education because it was what I wanted to do, and I had the bent for 
it. The CU School of Medicine gave me the opportunity to do it.” 
After graduation, Farrington completed a fellowship at the Cleveland 
Clinic. In 1956, he established his practice in Boulder and served as as-
sistant clinical professor of medicine at the CU School of Medicine until 
1987. In addition, Farrington developed the first intensive and critical 
care pulmonary medicine program at Boulder Community Hospital — 
the first at a community hospital in Colorado — where he taught his 
fellow doctors and nurses about respiratory care. 
Through the years, Farrington has received numerous honors for his 
commitment to CU, including the Medical Alumni Association’s Silver 
and Gold Award, the George Norlin Award, the Board of Regents Medal, 
and the University Medal for Distinguished Service Award. He is also 
a past president of the School of Medicine Alumni Association and the 
CU-Boulder Directors Club. An active member of CU alumni associa-
tions since the early 1960s, Farrington continues to further the vision of 
the university. He, along with other classmates, helped to establish the 
Class of 1952 Scholarship Endowment. 
“His latest gift to CU — that curious menagerie of texts — are in good 
hands at the Health Sciences Library,” which houses more than 112,000 
books and 30,000 e-journals, says Deputy Director Melissa De Santis.
Farrington’s donated books, which can be seen by appointment, will be 
kept in a climate-controlled, secure vault.  
“If books fall apart, nobody can use them,” says Emily Epstein, a catalog-
ing librarian at the Health Sciences Library. “We lose information about 
what physicians knew about diseases and medical treatment at the time, 
and there’s also evidence we find in margins like signatures or notes. 
There is data to be mined from it.”
A Curious Menagerie of Texts
Alum’s gift of rare books offers a glimpse of medical history
By Melanie M. Sidwell 
Books donated to the Health Sciences 
Library by Dr. John Farrington
•	 De	anima	brutorum by Thomas Willis 
(1676)  
•	 Opera	omnia by Thomas Willis (1676) 
•	 Diphtheria by Daniel Slade (1864) 
•	 Fourteen	weeks	in	human	physiology	by 
Joel Dorman Steele (1874) 
•	 Professor	Röntgen’s	‘X’	rays	and	their	
application	in	the	new	photography by 
August Dittmar (1896)  
John Farrington, MD '52, donated five rare books to the School of Medicine. 
Photo by Trevr Merchant. 
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Despite all the medical advances that have occurred since these historic 
books were published, some aspects of being a physician never change, 
Farrington says. 
“If you don’t know where you’ve been, you don’t know where you’re go-
ing. It’s important for medical students to know their ancestry as physi-
cians and see the evolution of medicine,” he says. “But some of the skills 
of the old clinicians are still valuable. The stethoscope is still important. 
You need to learn to sit and talk to people and put them at ease — treat 
them like they are the only patient you’ve got, and for the moment you 
have them in front of you, that’s true.” 
MEDICAL ALUMNI ASSOCIATION 
PARTNERS WITH LOCAL CULTURAL 
PROGRAMS
Opera Event a Great Success
Arts and culture play an invaluable role in shaping vibrant communities. 
The Medical Alumni Association has long recognized this impact and is 
committed to adding more cultural, artistic, and educational content to 
future alumni programming. Examples of past programs include behind-
the-scenes tours at art museums, performances by renowned symphony 
orchestras, and evenings at the opera.  
Last November, in partnership with Opera Colorado, the Medical 
Alumni Association hosted A Night at the Opera and performance of Gi-
useppe Verdi’s Aida. With more than 375 CU School of Medicine alumni, 
housestaff, students, faculty, and staff in attendance, the event created 
new milestones — it was one of the best-attended Medical Alumni As-
sociation events in many years and the Association was the largest group 
hosted by Opera Colorado.  
The Association is grateful to those who attended and supported the 
event. We look forward to seeing alumni soon as at future alumni out-
reach and engagement activities.  
NEW MEMBER BENEFITS 
Medical Alumni Association members are now eligible for dis-
counted tickets to performances including those by CU Presents, 
Opera Colorado, the Colorado Symphony, and the Colorado Ballet.  
Take advantage of these discounts, reconnect with fellow CU School 
of Medicine alumni, and join the Association’s efforts to grow ap-
preciation for the arts.  
To learn more or suggest other partnership opportunities in your 
area, please contact the Office of Alumni Relations at 303-724-2518 
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Transformational Research  
Funding Projects
At his first State of the School address in 
January University of Colorado School of 
Medicine Dean John J. Reilly, Jr., MD, named 
five recipients of Transformational Research 
Funding awards. 
In fall 2015, Reilly announced a competitive 
process for applicants to seek funding for 
proposals that would position the University 
of Colorado School of Medicine as a leader 
in cutting-edge and emerging fields, attract 
extramural funding, help recruit and retain 
outstanding faculty, enhance education and 
training, and positively impact human lives 
and society in Colorado, the nation and the 
world.
The proposals were selected by an external 
review committee.
The five selected proposals are:
Patient-Integrated Value and Organizational 
Transformation and Data Sciences for Health 
(PIVOT|DaSH), which aims to build infrastruc-
ture, develop methods and establish imple-
mentation pathways to prepare for population 
health.
The team leaders are Jean Kutner, MD, MPH, 
professor of medicine, chief medical officer for 
University of Colorado Hospital and associ-
ate dean for clinical affairs for the School of 
Medicine; Michael Ho, director of the Denver 
VA Center of Innovation; Lisa Schilling, MD, 
MSPH, professor of medicine and medical 
director of the Office of Value Based Perfor-
mance; and Michael Kahn, MD, professor of 
pediatrics, director of informatics, Children’s 
Hospital Colorado, and interim director of 
Health Data Compass.
The GI and Liver Innate Immune Program, 
which aims to diagnose, treat and understand 
gastrointestinal and liver disease in children 
and adults. 
The team leaders are Sean Colgan, PhD, 
professor of medicine and immunology; Ron 
Sokol, MD, professor of pediatrics, chief of 
gastroenterology, hepatology and nutrition 
and director of the Colorado Clinical and Trans-
lational Sciences Institute; and Hugo Rosen, 
professor of medicine and chief of the Division 
of Gastroenterology and Hepatology.
The Human Immology and Immunotherapy 
Initiative, which will build on existing 
strengths in immunology to capture the next 
wave of development in the field, treating 
and, in many cases curing, diseases by inter-
ventions that target immunological functions. 
The team leaders are John Cambier, PhD, 
chairman of immunology and microbiology; 
Andrew Fontenot, MD, professor of medicine 
and head of the Division of Allergy and Clinical 
Immunology; and Dan Theodorescu, MD, PhD, 
professor of surgery and pharmacology and 
director of the University of Colorado Cancer 
Center.
The RNA Bioscience Initiative, which will focus 
on developments in understanding of RNA 
biology, including its biogenesis and structure, 
the identification of functions for various 
classes of RNAs, establishing the role of RNA 
in disease and exploring RNA-based and RNA-
targeted therapies.
The team leaders are David Bentley, PhD, pro-
fessor of biochemistry and molecular genetics; 
Richard Davis, PhD, professor of biochemistry 
and molecular genetics; Jay Hesselberth, 
PhD, assistant professor of biochemistry 
and molecular genetics; Eric Poeschla, MD, 
professor of medicine and chief of the Division 
of Infectious Diseases; Linda van Dyk, PhD, 
associate professor and vice chair of immunol-
ogy and microbiology; and Craig Jordan, PhD, 
professor of medicine and chief of the Division 
of Hematology.
The Consortium for Fibrosis Research and 
Translation, which will impact human health 
through discoveries of fundamental mecha-
nisms of fibrosis, and using this knowledge 
as a platform for developing transformative 
therapies to treat fibrotic disease, covering 
multiple organs. The center will also ad-
dress organ regeneration, inflammation and 
epigenetics. 
The team leaders are Timothy McKinsey, PhD, 
associate professor of medicine and associate 
division head for translational research in the 
Division of Cardiology; and Mary Weiser-Evans, 
PhD, professor of medicine. 
The School is supporting proposals, each with 
a five-year budget totaling between $10 mil-
lion and $20 million. Funding for the propos-
als comes from clinical earnings of the faculty, 
from annual financial support from the Uni-
versity of Colorado Health and philanthropy, 
including a commitment of $15 million by The 
Anschutz Foundation. No state-appropriated 
funding or student tuition or fees are being 
used for the Transformational Research Fund-
ing awards. 
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In announcing the selections during the State 
of the School address, Reilly said the choices 
were the most highly rated by the external 
reviewers and meet several goals. 
“We wanted to try to fund the most highly 
rated programs from our study section and do 
a variety of other goals, including cross-disci-
plinary collaboration, involvement of partners 
from other institutions, include a variety of 
topics where we can have high impact, a 
spectrum of age of the patients affected by 
this type of research. 
“There are lot of worthy projects that we did 
not have the resources to fund. I think my job 
is to go out and try to identify the resources to 
capitalize on those other opportunities. That 
said, I’m very proud of these projects. I think 
they encompass a broad swath of areas. It 
incorporates a lot of our existing faculty. It’s 
going to provide the opportunity to build our 
research capabilities and attract a lot of new 
faculty to this campus.” 
Additional detail about the selected proposals 
is available on the School of Medicine’s web-
site: http://medicine.ucdenver.edu/TRF
National Behavioral Health  
Innovation Center Established
The University of Colorado Anschutz Medical 
Campus announced in March the establish-
ment of the National Behavioral Health Innova-
tion Center, made possible with a $10 million, 
five-year commitment from The Anschutz 
Foundation.
The National Behavioral Health Innovation 
Center (NBHIC) is designed as a “virtual cen-
ter” to serve people in Colorado and across the 
nation, by identifying and implementing be-
havioral health solutions, making connections 
to national experts, and providing resources to 
build connections among community leaders 
across the state.
“There are few areas of health care more im-
portant and less understood than mental and 
behavioral health,” says CU President Bruce 
Benson. “By investing in a center with a focus 
on finding innovative approaches to preven-
tion, identification and treatment through 
intensive collaboration with partners all across 
our state, The Anschutz Foundation is invest-
ing in a brighter future for all people who 
suffer from a behavioral health condition. We 
couldn't be more grateful for their continued 
philanthropic partnership.”
Matt Vogl, MPH, has been named NBHIC 
executive director, reporting jointly to CU 
Anschutz Chancellor Don Elliman and to an 
NBHIC board of directors made up of promi-
nent community, business, philanthropy and 
health care leaders who will guide the NBHIC’s 
work and ensure its relevance and sustainabil-
ity into the future.
Global Down Syndrome Founda-
tion Supports Research
The Global Down Syndrome Foundation 
announced in March that it is providing $1 
million in funding for eleven new studies at 
the School of Medicine’s Linda Crnic Institute 
for Down Syndrome, and three new clinics 
at the Anna and John J. Sie Center for Down 
Syndrome at Children's Hospital Colorado.
“One cannot overemphasize the importance 
of the diversity in this research,” said Tom 
Blumenthal, PhD, executive director at the 
Crnic Institute. “The potential findings on 
the horizon from this research, made possible 
by funding from Global, may play a role in 
significant discoveries leading to an enhanced 
quality of life for those with Down syndrome 
that could possibly benefit the typical popula-
tion as well.”
The Global Down Syndrome Foundation pro-
vides outreach and raises funds for the Linda 
Crnic Institute for Down Syndrome on the 
Anschutz Medical Campus -- the first and only 
academic home for Down syndrome research 
and medical care in the United States. Global 
funding helps to underwrite impactful basic 
and clinical research benefiting people with 
Down syndrome.
Four of the 2016 grant recipients will focus on 
the immune system; increasing evidence sug-
gests that malfunction of the immune system 
in people with Down syndrome may be linked 
to their higher risk for leukemia, autoimmune 
disorders, and cognitive impairment.
• Brianne Bettcher, PhD, assistant professor 
of neurosurgery at the School of Medicine, 
will investigate the correlation between 
biomarkers of inflammation, brain struc-
ture, and neuropsychological functioning 
in adults with Down syndrome with an 
emphasis on those with early stages of 
Alzheimer's disease.
• Steven Maier, PhD, Distinguished Profes-
sor of Psychology and Neuroscience at the 
University of Colorado-Boulder, will test 
the impact of anti-inflammatory therapies 
on learning and behavior using a mouse 
model of Down syndrome.
• Christopher Porter, MD, associate profes-
sor of pediatrics at the School of Medicine 
and in the Center for Cancer and Blood 
Disorders at Children’s Hospital Colo-
rado, will employ advanced technology 
to define, with unprecedented detail, the 
impact of trisomy 21 on the amount and 
function of the many types of immune 
cells in the human body.
• Kelly Sullivan, PhD, instructor of phar-
macology at the School of Medicine, will 
focus on a specific group of proteins, 
known as interferons, which play potent 
and widespread roles in the immune sys-
tem. This research will define the impact 
of modulating interferon activity on cells 

















The Death of My Patient Last Week
By L.A. Kahn
Eight days ago, my patient died. 
His name escapes me, though I 
used it many times in the hours 
that I knew him; its recollection 
is lost in the wash of biological 
details I collected and faithfully 
catalogued. The human spirit 
may exist beyond the material 
plane, but the mundane markers 
of daily wear are what we see 
and respond to. Like concentra-
tion camp prisoners stripped of 
clothes and hair, bereft of the 
symbols of the lives they had, there is an irrevocable loss of per-
sonality that occurs upon hospitalization. Patients replace their 
chosen clothing with hospital gowns and skidproof socks, carry 
machines in their flesh tethering them to information networks, 
require assistance in removing waste from their orifices. They 
merge into an undifferentiated mass of needs, one beast calling 
out from many beds, a smudge of human suffering distinguished 
only by the order in which their systems break down. I don’t 
remember my patient’s name because it was irrelevant; I instead 
remember the course of events that took him, the shocking CT 
scan, the failed surgical attempt, the pressors and traumas of 
the last hours. The detail of my documentation was in his death, 
not his life.
On hospital days, the dichotomy becomes unbearable: five physi-
cians in a ward room, dressed exhaustively in professional gear, 
shoes shined, ties and badges abreast and clipboards in hand. 
We stand around the bed. The patient below us - barefoot, pasty, 
ungarbed. We talk to each other about the patient, in front 
of the patient, a convention unacceptable in the bright world 
outside. We tell each other how much salt is in their blood, 
how much blood is in their urine, how much urine they have 
produced in the past twenty-four hours. We speak in code about 
their perceived motives and desires. We tell each other what we 
think we should do, confirm and veto plans, roll the patient back 
and forth to hear various organs, examine tubes carefully. We 
make mental lists of things to do as we answer their questions, 
and rub antiseptic gel on our hands as we walk briskly out of the 
room to the next failing creature.
My patient who died eight days ago was a freshwater biologist 
before he retired. He and his wife enjoyed going to concerts 
and eating out around town. He died the night I admitted him, 
suddenly, unexpectedly, amidst much rancor between medical 
teams. There was blame to spare the next morning. I scrolled 
through his CT scans again and again, searching for a sign we’d 
missed on admission, a predictor of what the next twelve hours 
would bring. I didn’t see his body or his family; they were inac-
cessible, buried in the ICU behind a cluster of professionals. I 
wanted to see his wife - to do what? Cry with her? Apologize for 
laughing so casually the night before? Share my bewilderment, 
as though it could provide solace?
My patient’s CT scan from admission stays with me: the black 
and gray images of his colon, the hunt for signs of inflamma-
tion, the contested slide that might have showed dead tissue. 
I remember, too, his physical exam from the night before, his 
abdomen distended but not taut, tender to the touch in only a 
few places, his lungs clear, his ankles a little swollen. His feet 
were sensitive, from some longstanding nerve damage. I remem-
ber how much oxygen he needed and that his potassium was 
normal. I do not remember his name.
L.A. Kahn is a member of the Class of 2017 at the School of Medicine. This 
essay originally appeared in The Human Touch, a journal of poetry, prose and 
visual art by students, faculty and staff on the Anschutz Medical Campus.
Homo whatsit? Insights into evolution and diversity 
By Caley M. Orr, PhD
As a PhD in paleoanthropology, my primary qualifica-
tion for employment at a medical campus is the ability 
to properly name human body parts (I teach gross 
anatomy). But my research examines the evolution of 
human anatomy and behavior documented in the fos-
sil record. That record indicates that humans (Homo 
sapiens) are the sole survivors of a once a bushier 
“hominin” family tree, which included other species of 
our own genus Homo. 
We have long 
known that Homo 
was preceded by 
more ape-like 
genera such as 
Ardipithecus (two 
species found in 
Ethiopia between 
5.2 million-4.4 




in East and South 
Africa between 4.1 
million-1.2 million 
years ago). The ear-
liest Homo speci-
men is 2.8 million 
years old, and the 
genus subsequently proliferated into a half-dozen species or more. The 
earliest (Homo habilis and Homo rudolfensis) appear in Africa, but by 
1.8 million years ago, the intrepid Homo erectus dispersed across Africa 
and Eurasia. Early Homo used stone tools, and scavenging and hunting 
were part of the lifestyle. Such behavioral shifts contributed to the evolu-
tion of the reduced jaws and teeth that characterize our genus. Rela-
tively late-surviving Homo representatives include the Neanderthals of 
Europe and the Middle East, the diminutive and isolated “hobbits” from 
Indonesia (Homo floresiensis), and a mysterious lineage known only by 
DNA from a finger bone found in a Siberian cave (the Denisovans). Some 
archaic hominins overlapped in time with Homo sapiens (who appear by 
~200,000 years ago) and may have interacted with humans.
Many details about the anatomical and behavioral transitions at the root 
of Homo have remained obscure, but a recent discovery offers unprec-
edented insights. Last year, along with an international team led by Lee 
Berger of Wits University, I was invited to study a cache of bones found 
deep within the Rising Star Cave in South Africa. Over 1,500 specimens 
represent a minimum of 15 individuals ranging from infants to the elder-
ly, and these are distinct enough to name a new species—Homo naledi. 
The geological age is uncertain, but the overall primitive pattern of mor-
phology suggests the lineage may have diverged early in Homo evolu-
tion. The skull has a low-lying contour with pronounced brow ridges, no 
chin, and a small brain cavity (just over one third the size of a human’s). 
Nevertheless, small jaws and teeth place it within the genus Homo. A 
mix of ape-like and human-like traits characterize the shoulders, hips, 
and hands. The wrist shows undeniably human-like features facilitating 
grips that make us adept tool users. However, strongly curved fingers 
and a rather ape-like shoulder reflect a robust capacity for tree-climbing. 
In contrast, the lower limb indicates a bipedal gait. Indeed, Homo naledi 
demonstrates that primitive members of Homo were still occupying two 
worlds, and that the anatomy was adapted in compromise. 
How the Homo naledi skeletons came to occupy Rising Star remains a 
mystery. Many bones were in articulation and almost no other animals 
were recovered. There is no evidence that bones washed in or were 
transported by carnivores. The chamber is difficult to access, requiring 
long crawls through tight spaces. Although controversial, the “least bad” 
hypothesis is that bodies were dragged in (with difficulty) for disposal 
or possibly ritual. If substantiated, it may provide a glimpse of ancient 
funerary practices. 
Fossils are still being recovered from 
Rising Star, and new sites are discov-
ered at a rapid pace. Novel finds 
combined with breakthroughs in 
the study of morphology and an-
cient DNA ensure more surprises 
to come. It is an exciting time to 
be a scientist studying human 
evolution, and it is an honor 
to represent CU Anschutz in 
that endeavor.
Caley M. Orr, PhD, is an 
assistant professor in the 
Department of Cell and 
Developmental Biology. 
This essay is adapted 
from a public lecture 
given as a part of the 
2016 Science Lounge 
series at the Denver 
Museum of Nature 
and Science.
 FACULTY MATTERS
A stethoscope is a universal symbol of one’s commitment 
to the art and science of medicine. Each incoming CU medical 
student receives a new stethoscope branded with the Medical Alumni 
Association seal. This gift symbolizes their entrance into the medical 
profession and a proud community of CU-educated physicians. By 
sponsoring one or more stethoscopes, you join a decades-old tradition. 
The Medical Alumni Association Stethoscope Sponsorship Program 
forges a meaningful relationship between alumni and medical students. 
Your support creates and fosters a lifelong bond. 
To support the Stethoscope Sponsorship Program, 
visit giving.cu.edu/stethoscope or call 303-541-1290.
“The first thing the students do is 
put on the white coat and drape 
the stethoscope around their 
neck. It is then that they truly feel 
like a doctor.”
Give the symbol 
of medicine.
Become part of 
the tradition. 
—H. A. Fonken, MD (’59)
AMC 16003 CU Medicine Stethoscope Ad.indd   3 3/15/16   8:46 AM
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